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ABSTRACT 
Mammalian lungs have evolved with the environment as organs with the largest 
interface to the outside world. Our lungs exist in a state of homeostasis despite their 
consistent exposition to thousands of exogenous chemicals, particles and 
microorganisms carried by the air. As previously described for the gut and the skin, a 
high diversity of microbes lives and prospers in interaction with their host on the 
pulmonary surface as well, thereby connecting us to the environment. However, 
imbalances between beneficial and pathogenic microbes in this complex biological 
system can cause acute or chronic diseases. From these empirical observations, the 
human microbiome, in its diversity, interacts actively with the host immunity.  
This project aims to investigate the effect of two classes of bacterial signaling 
molecules on the inflammation dynamics of the lung, focusing on differentiation of T 
helper (Th) cells, activation (polarization) of alveolar macrophages (AM), and wound 
healing and repair during an inflammatory response. On one hand, the quorum 
sensing (QS) molecule 3-oxo-C12-HSL (AHL), produced by the pathogenic bacterium 
Pseudomonas aeruginosa (PAO1 strain) and on the other hand the D-tryptophan (D-
Trp), amino acid secreted by probiotic lactic acid bacteria, like Lactobacillus casei, 
were studied as examples of two classes of molecules involved in having a potential 
therapeutic interaction with the host.  
First the effects of the 3-oxo-C12-HSL on murine Th cells, especially Th17 and Th2-cell 
differentiation, were investigated. 3-oxo-C12-HSL increased interleukin 17 (IL-17) 
production of Th17 cells. However, it did not influence interleukin 4 (IL-4) production 
in Th2 differentiated cells. IL-17, mainly produced from Th17 cells, is a pro-
inflammatory cytokine responsible for the chemoattraction of leukocytes to the site of 
inflammation; whereas IL-4, produced from Th2 cells and a key regulator of adaptive 
immunity, is also involved in M2-polarization of macrophages, thereby promoting the 
resolution of inflammation and wound repair. Altogether these results showed that 3-
ABSTRACT 
13 
oxo-C12-HSL stimulation of differentiated Th17 cells supported IL-17 production and 
might thereby promote the inflammatory response. 
During a bacterial lung infection, the primary immune response is conducted by 
tissue resident, alveolar macrophages (AM). To study the effect of AHLs on alveolar 
macrophage polarization, M0-naïve AM (MH-S cell line) were polarized with 
lipopolysaccharide (LPS) towards M1-polarization and simultaneously treated with 
AHLs (60 μM). Interestingly, both the expression and secretion of the pro-
inflammatory cytokines Tumor Necrosis Factor α (TNFα) and Interleukin 1 beta (IL-
1β) rose by the cotreatment with AHLs, mostly 3-oxo-C12-HSL, suggesting that the 
development of M1 AM and thus an inflammatory response was supported. D-Trp 
treatment (10-100 μM), simultaneous applied to M1-polarization, led also to an 
increase of TNFα secretion, suggesting that D-Trp contributed to a pro-inflammatory 
modulation of the AM as well. Then again, both 3-oxo-C12-HSL and D-Trp 
treatments supported alternative, IL-4 triggered AM polarization (M2-polarization), 
characterized by increased expression of the markers Arginase 1 (Arg1) and Mannose 
Receptor C-Type 1 (Mrc1). The latter results suggest that M2-polarization could be 
enhanced by 3-oxo-C12-HSL and D-Trp, thereby eventually promoting M2 dependent 
repair pathways during the resolution phase of inflammation. In aim to test the 
influence on repair pathways, a lung epithelium coculture model, consisting of AM 
(MH-S) and alveolar epithelial cells type 2 (AECII; LA-4 and MLE-12 cell lines) was 
investigated. The coculture wound healing assays however revealed that 3-oxo-C12-
HSL, and D-Trp to a lesser extent, inhibited in vitro epithelial barrier function and 
healing independently even from a by LPS induced inflammatory response. Similarly, 
Pseudomonas aeruginosa’s culture supernatant, containing secreted AHL, greatly 
impaired epithelial wound healing. Also in vivo, in an acute lung injury (ALI) model, 
created by intratracheal LPS delivery into the lung of BALB/c mice, therapeutically 
treatment with 3-oxo-C12-HSL, at a dose of 1200 μM (corresponding to a local strong 
PAO1 infection) failed to reduce polymorphonuclear neutrophil (PMN) recruitment 
in the airspace of the lung after acute lung injury. This altogether rejects the 
hypothesis of therapeutic effects of AHL during inflammatory conditions of the lung. 
ABSTRACT 
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In contrast, D-Trp treatment reduced PMN recruitment in the ALI model, 
accompanied by a trend in declined bronchoalveolar lavage (BAL) levels of the 
chemokine (C-X-C motif) ligand 1 (CXCL1), while L-Trp had no comparable effect. 
mRNA analysis of the whole lung homogenate confirmed that the expression of 
CD11b (a marker for PMNs and inflammatory macrophages) was mildly reduced 
after D-Trp instillation. These results collectively confirmed the anti-inflammatory 
effects of D-Trp in an injured lung. Since D-Trp can have transcriptional signaling 
activity via the aryl hydrocarbon receptor (AhR), whose immunological importance is 
gaining more and more attention, the involvement of this pathway was investigated 
in bone marrow derived macrophages (BMDM) from AhR-/- (AhRtm1Bra) mice. D-Trp 
treatment of BMDM caused an AhR dependent expression of the prototypic AhR 
target gene cytochrome P450-1A1 (Cyp1a1) and also indoleamine 2,3-dioxygenase 1 
(Ido1), while L-Trp had no effect. Since Ido1 metabolizes tryptophan to kynurenine, 
which in turn is sensed by AhR, this suggests a positive feedback loop. Finally, D-Trp 
but not L-Trp treatment of BMDM also reduced the expression of the LPS 
stimulated M1 markers interleukin-6 (Il-6) and Nos2, and enhanced the by IL-4 
stimulated M2 markers Arg1 and Mrc1, all in an AhR dependent manner. 
In summary, the results suggest not the investigated AHL 3-oxo-C12-HSL, but rather 
D-tryptophan as a potential target of respiratory medicine, due to its receptor specific 
immunomodulatory, anti-inflammatory role on macrophages and alveolar 
macrophages, which might be used to alleviate pulmonary inflammation or support 
its resolution. 
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ZUSAMMENFASSUNG 
Die Lungen von Säugetieren haben sich ihrer Umwelt angepasst. Dabei haben sie die 
größte Oberfläche im menschlichen Körper entwickelt, die mit der Außenwelt in 
Kontakt ist. Unsere Lunge existiert dabei in innerer Homöostase trotz ständiger 
Exposition von tausenden exogener Chemikalien, Partikeln und Mikroorganismen in 
der Atemluft. Wie bereits für den Darm und die Haut beschrieben, lebt auch auf der 
Lungenepitheloberfläche eine hohe Diversität von Mikroorgansimen in Interaktion mit 
ihrem Wirt und ist damit ein Bindeglied zwischen unserer Lunge und der Außenwelt. 
Allerdings können Ungleichgewichte zwischen gutartigen und pathogenen Mikroben 
dieses komplexe biologische System zu akuten als auch chronischen Erkrankungen 
verändern. Durch empirische Untersuchungen wurde festgestellt, dass das humane 
Mikrobiom in seiner Diversität aktiv mit dem Immunsystem des Wirts interagiert. 
Dieses Projekt hatte als Ziel, die Effekte von zwei bakteriellen Signalmolekülen auf 
die Entzündungsdynamik der Mäuselunge zu untersuchen. Dabei wurde auf folgende 
Funktionen fokussiert: die Differenzierung von T-Helfer-Zellen (Th), die 
Differenzierung von Alveolarmakrophagen, und die Wundheilung während einer 
Entzündungsantwort. Einerseits waren es Quorum sensing-Signalstoffe vom N-Acyl-
homoserinlacton (AHL)-Typ (w.z.B. 3-oxo-C12-HSL) des Gram-negativen pathogenen 
Bakteriums Pseudomonas aeruginosa (PAO1-Stamm), sowie andererseits D-
tryptophan (D-Trp), welches vom Gram-positiven probiotischen Bakterium 
Lactobacillus casei gebildet wird. Beiden werden potenziell therapeutische 
Wechselwirkungen mit dem Immunsystem des Wirts zugeschrieben. 
Zunächst wurden die Effekte verschiedener AHL-Strukturen auf die Differenzierung 
von T-Helferzellen (Th), besonders im Bezug auf die Th17- und Th2-
Zelldifferenzierung, untersucht. 3-oxo-C12-HSL induzierte eine erhöhte Interleukin 17 
(IL-17) Produktion in Th17 Zellen, während 3-oxo-C4-HSL und C12-HSL keine 
Stimulierung zeigten. Im Gegensatz konnte 3-oxo-C12-HSL die Interleukin 4 (IL-4) 
Produktion der Th2 Zellen nicht induzieren. IL-17, hauptsächlich produziert von Th-
ZUSAMMENFASSUNG 
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17 Zellen, ist ein entzündungsförderndes Zytokin, welches für die Zytokin-getriebene 
Anlockung von Immunzellen in Richtung der Entzündung verantwortlich ist. Auf der 
anderen Seite steht IL-4, welches von Th2-Zellen produziert wird, und eine 
Schlüsselfunktion in der Regulation der adaptiven Immunantwort hat. IL-4 ist 
verantwortlich für die Rekrutierung von M2-Makrophagen, welche wiederum die 
Entzündung herunterregulieren und dabei zur Wundheilung beitragen. Zusammen 
zeigen die Ergebnisse für AHL, dass 3-oxo-C12-HSL durch die erhöhte Stimulation der 
IL-17 Produktion zur Entzündungsreaktion beitragen kann. 
Die primäre Immunantwort während einer bakteriellen Entzündung wird durch 
gewebespezifische alveolare Makrophagen (AM) ausgeführt. Um den Effekt von AHL 
auf AM zu untersuchen, wurden zunächst M0-naive AM (MH-S Zelllinie) durch 
Lipopolysaccharid (LPS) zu M1-Makrophagen (M1-AM) stimuliert und simultan mit 
AHLs behandelt (60 μM). Interessanterweise wurde die Expression und Sekretion der 
Zytokine Tumornekrose-Faktor α (TNFα) und IL-1β erhöht durch vor allem 3-oxo-
C12-HSL. Dies weist darauf hin, dass AHLs eine Rolle in der Verstärkung M1-AM 
Immunantwort spielen. Zusätzlich induzierte auch D-Trp eine gesteigerte TNFα 
Sekretion; dies deutet ebenfalls auf eine Rolle von D-Trp in der Verstärkung der 
entzündlichen Immunantwort durch M1-AM hin. Auf der anderen Seite induzierten 
sowohl 3-oxo-C12-HSL als auch D-Trp die alternative AM Polarisierung (M2-
Polarisierung), welche durch die Expression der M2-Marker Arginase 1 (Arg1) und 
Mannose-Rezeptor C-Typ 1 (Mrc1) gekennzeichnet war. Diese Ergebnisse deuten 
darauf hin, dass die M2-Polarisierung durch AHL und D-Trp verstärkt wird und dass 
3-oxo-C12-HSL und D-Trp dadurch eventuell M2-abhängige Reparaturmechanismen 
während der Entzündungsauflösung vorantreiben. 
Um den Einfluss auf Reparaturmechanismen zu untersuchen, wurde ein Ko-
Kultursystem verwendet, welches aus alveolaren Typ-2 Zellen (AECII; LA-4 und 
MLE-12 Zelllinien) und AM (MH-S) bestand. Die Behandlung der Ko-Kultur aus 
AECII und AM mit AHL führte zur Reduktion von TNFα, IL1β und Nitric-Oxide 
Synthase 2 (Nos2), die als M1 Entzündungsmarker gelten. Zusätzlich wurde die 
Expression des M2-charakterisierenden Gens Arg1 erhöht. Auf der anderen Seite 
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blockierten sowohl 3-oxo-C12-HSL als auch D-Trp, obwohl letzteres zu einem 
geringeren Grad, die in vitro Wundheilung der Epithelzellen. Diese Ergebnisse waren 
unabhängig von der Stimulation durch LPS. Des Weiteren wurde ein in vivo Modell 
für akute Lungenschädigung (ALI) etabliert, bei dem die Lungen von BALB/c 
Mäusen mit LPS behandelt wurden. Die Behandlung mit AHL (1200 μM, äquivalent 
zu einer starken lokalen PAO1 Infektion) konnte die Rekrutierung/Anzahl an 
polymorphonuklearen Neutrophilen (PMN) in den Atemwegen nicht reduzieren. 
Allerdings gelang dies durch Behandlung mit D-Trp. Es konnte gezeigt werden, dass 
die Behandlung mit D-Trp die Produktion des Chemokin (C-X-C motiv) Liganden 1 
CXCL1 in der BAL reduzierte. Die Analyse der mRNA der gesamten Lunge ergab 
eine Reduktion des PMN-Markers CD11b. Diese Resultate unterstreichen die 
entzündungshemmende Wirkung von D-Trp in Lungenschädigungen. 
D-Trp ist auch bekannt als Agonist des Aryl-Hydrocarbon-Rezeptors (AhR). Die 
Bindung von D-Trp an AhR führt zur Translokation von AhR in den Zellnukleus. 
Zahlreiche Mechanismen sind beschrieben, die nach Aktivierung von AhR initiiert 
werden. Darunter befindet sich das Enzym Indoleamine 2,3-Dioxygenase 1 (IDO1), 
welches D-Trp zu Kynurenine katabolisiert, sowie das Zytochrom P4501-1A 
(CYP1A1), welches in den xenobiotischen Metabolismus involviert ist. 
Expressionsanalysen in aus Knochenmark stammenden Makrophagen (BMDM) von 
AhR+/- und AhR-/- Mäusen (AhRtm1Bra) zeigten, dass die Expression von IDO1 und 
CYP1A1 von D-Trp abhängig waren (100 μM) sowie von der Anwesenheit von AhR, 
nicht jedoch von der Anwesenheit von L-Trp. Um die Funktion von AhR in der 
Immunantwort der Lunge zu untersuchen, wurden die Expression von IL-6 und Arg1 
in AhR-/- BMDM-Mäusen untersucht. Die zuvor gezeigte entzündungshemmende 
Wirkung von D-Trp war auch in den AhR-/- Zellen präsent. Die mRNA Expression 
von AhR wurde durch D-Trp verstärkt. Dies läßt eine von D-Trp oder dessen 
Metaboliten abhängige Rückkopplungsschleife vermuten. Die gesteigerte metabolische 
Aktivität von D-Trp ist konsistent mit der Regulation der Immunantwort durch 
Entzündungs-stimulierte AM. Daher trägt D-Trp potenziell zu einer verstärkten oder 
schnelleren Auflösung der Immunantwort bei. 
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Zusammenfassend konnte in dieser Arbeit gezeigt werden, dass nicht AHL, sondern 
eher D-Trp ein potentielles Therapeutikum in der Atemwegsmedizin werden könnte. 
Durch seine rezeptorspezifischen, immunmodulatorischen und 
entzündungshemmenden Funktionen in Makrophagen sowie auch in alveolaren 
Makrophagen könnte D-Trp zu einer Verminderung der Entzündung in der Lunge 
beitragen bzw. die Auflösung der Entzündung unterstützen. 
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INTRODUCTION 
1. Breathing the world 
1.1. The lung biology and function 
Mammals and other air-breathing animals transport the oxygen of the air to their 
bloodstream and organs through the respiration of the lung. Healthy human 
individuals breathe around 10000 L of air per day. The carbon dioxide generated by 
the organisms is afterwards released from the bloodstream back to the atmosphere 
during the expiration. Several key anatomical elements are needed to operate the 
lung function and maintain its integrity. The lung carries out two main physiological 
tasks; conducting the airflow and performing the gas exchanges. 
The upper respiratory tract (nose, pharynx and larynx and trachea), down to the 
bronchi and bronchioles subdivisions, guides the air to the lower respiratory tract 
(terminal bronchioles and alveoli). Exogenous particles are retained away from the 
alveolar sac, where the gas exchange takes place. Each subunit has a different role 
and carries a different set of specialized cells to fulfill its function. The lung alveolar 
duct combined with the alveoli consists of an extraordinary surface of approximately 
75 m² [1]. 90% of the gas exchange occurs at the surface of the alveoli. 
 
1.2. The microbes, friends and foes 
The outside world is not only a vector of gases and food, but also the home of a high 
diversity of microorganisms. This study focuses on bacteria, which are ubiquitous on 
earth: from the soils to the oceans and the air. They are present everywhere and form 
complex communities adhering to surfaces in biofilm structures. More than 10000 
species have been discovered, even though the actual diversity is postulated to be 
between 5 and 10 million [2]. Bacteria can be beneficial to higher organisms as well as 
harmful or even detrimental. 
Different bacteria can be beneficial or harmful for humans. Bacteria are divided into 
two super families depending on the staining of their cell wall (Gram-staining): the 
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Gram-negative and the Gram-positive bacteria. On one hand, the Gram-positive 
bacteria (i.e. Bacillus, Listeria, Staphylococcus, Lactobacillus) have a thick 
peptidoglycan layer – containing also D-amino acids – coupled to a thin plasma 
membrane. In contrast, Gram-negative bacteria (i.e. Escherichia coli, Pseudomonas 
aeruginosa), have a more complex cell envelope consisting of a much thinner 
peptidoglycan layer coupled to a lipopolysaccharide (LPS) decorated outer 
membrane, separated by a periplasm from the plasma membrane (Figure 1). 
 
 
Figure 1. Gram-positive and -negative cell wall structure. The membrane structure 
allows the classification between these two super families. 
 
2. The immunology of the lung  
Bacteria and humans have evolved jointly to a unique symbiotic holobiont [3]. The 
skin and the gut microbiota act as a protecting living barrier for the eukaryotic 
organism against pathogenic microbes. However, the lung surface structures need to 
be cleared of microbial biofilms to allow an efficient gas exchange. Since the air 
contains aerosolized potentially harmful particles and microbes, the immune system 
must continuously undertake defense measures to keep the organisms’ homeostasis. 
Therefore, humans possess complex immune responses, which can be divided into two 
categories: the innate and the adaptive immune system. 
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2.1. Innate response 
The innate immune system consists of a variety of non-specific immune cells, 
constantly surveilling the body, ready to be activated within the first minutes after a 
tissue injury or a cell infection is detected [4]. This evolutionary defense mechanism 
relies on the recognition of pathogen-associated molecular patterns (PAMPs) or host- 
derived damage-associated molecular patterns (DAMPs) [5]. The recognition of these 
patterns will trigger a fast onset of inflammation, characterized by the recruitment of 
leucocyte through chemical mediators (cytokines), the activation of the complement 
cascade, and the identification of the pathogen leading to the antigen presentation by 
the antigen presenting cells (APCs). Most innate leukocytes are issued from the bone 
marrow [6], where after a process of maturation [7–9] they are released to the 
bloodstream [10]: the mast cells, the phagocytes (i.e. macrophages, neutrophils and 
dendritic cells), the natural killer cells and the basophils and eosinophils. In this 
study, the main focus is on the innate immune response of the lung resident 
macrophages, called alveolar macrophages (AMs). 
The innate immune system is fast and efficient, however it is not designed to retain 
any information on the pathogens, nor provide long-lasting immunity to the host [11]. 
 
2.2. Adaptive/acquired response 
The adaptive immunity is triggered after antigen presenting cells (APC) had contact 
with a given antigen. These highly specialized cells were generated during the last 
infection and will be reactivated in the aim of the pathogen containment of 
destruction. The lymphocyte B (LBs) and T (LTs) are the main effectors of this 
specific and acquired response. Like most lymphocytes after their generation, LTs and 
LBs circulate in the bloodstream in the search of an activated APC. Upon 
stimulation by the antigen, LTs and LBs will undergo a phase of maturation and 
replication. LTs will either become T helper (Th), secreting cytokines to attract 
phagocytes, or T cytotoxic (Tc), tracking and killing infected cells. Activated B cells 
differentiate into plasma cells and will in turn produce pathogen specific antibodies, 
INTRODUCTION 
22 
directed to the source of the infection. After total removal of the pathogen causing 
the infection, the antigen pattern will be conserved as part of the immune memory. 
The speed of resolution is critical, since the continuation of homeostasis is the basis of 
the organism’s healthy state. The lingering inflammation of an organ leads to scaring 
and remodeling, possibly impacting its functions. In this work, the focus is on the 
lung immune response and particularly of its epithelium; the lung’s surface and 
vulnerable barrier to the outside world. 
 
3. The lung epithelial barrier/epithelium 
The lungs structure relies on a complex assembly of cells, forming a huge interface 
with the outside world (ca. 100 m² in humans). In this study, the importance is made 
not on the primary respiratory function of the lung parenchyma but on its ability to 
respond to the continuous flow of microbes (pathogens or saprophytes) reaching its 
surface. Among all the cell types present in the lung, four are lung specific: the AEC 
(Alveolar epithelial type I and II), the club cells and the ciliated bronchiolar cells 
(Figure 2). The lung consists of three distinct regions, populated by its own set of 
cells. From the trachea to the bronchus, the cells are predominantly ciliated cells –
which motion sweeps mucus and dirt up out of the lungs – and goblet cells producing 
the protective mucus lining the organ. These cells allow the clearance of the lung 
from dust and pathogens above the size of 3 μm through its so-called mucociliary 
escalator [12]. Further down in the bronchioles, ciliated cells become scarcer and 
goblet cells are replaced by club cells, protecting the bronchiolar epithelium by its 
surfactant secretion. Finally, down in the alveoli, there is no mucus lining, nor 
ciliated cells. Small particles (< 3 μm) and pathogens have no mechanical way to be 
expectorated or eliminated and end up “sitting” in the alveoli, potentially harming the 
epithelium. As previously explained, the respiratory, alveolar surface consists of two 
types of pneumocytes. The AECI are the specialized cells responsible for the 
oxygen/carbon dioxide gas exchange considering its thickness, comprised between 0.2 
and 2.5 μm, and covering 95-98% of the lung epithelium surface [13]. The AECII are 
more versatile and contribute to the secretion of pulmonary surfactant, reducing 
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surface tension as well as the replacement of AECI cells after cell damage. 
Inflammatory cytokine sensitivity and secretion from AECII also suggest that AECII 
contribute to the inflammatory response in the lung [14,15]. If the epithelium is not 
able to fully fulfill its barrier role, lung inflammation is the consequence. 
 
 
Figure 2. Overview of the pulmonary airways. The airways harbor various cell types, 
helping the lung clearance at all levels. Adapted from [16]. 
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4. Macrophages development and origin 
Monocytes are blood circulating leukocytes until their recruitment to a tissue and 
their differentiation into macrophages. In vertebrates, they are issued and generated 
continuously during the whole lifetime by bone marrow stem cells [17,18]. As 
previously explained, the macrophages play a critical role in the host defense systems. 
Chemotaxis will guide the monocyte precursors to the site of damage, where they will 
be differentiated into specialized macrophages depending to the targeted organ. The 
macrophages will undergo a final polarization, following a specific pathway, 
subdividing them into two different populations: M1 (classical) or M2 (alternative) 
macrophages (Figure 3). 
 
Figure 3. Schematic representation of M1 (classical) and M2 (alternative) 
macrophage polarization [19]. After activation and polarization, the AM will support 
either inflammation or repair and remodeling. 
INTRODUCTION 
25 
4.1. Macrophages polarization and functions 
4.1.1. M1: The classical activation 
Blood monocytes can be activated by macrophage colony stimulating factors (M-
CSF) to induce their differentiation in mature macrophages [20]. The differentiation 
of macrophages encompasses a spectrum of regulated genes. Macrophages are 
heterogeneous and possess particular plastic cellular phenotypes, finally allowing them 
to adopt their functionality to the respective surrounding environment. With respect 
to the activation state of macrophages, the (“classical”) M1 polarization describes AM 
involved in antimicrobial function [21–23]. As a phagocyte, its role will be mainly to 
recognize, engulf and digest pathogens, dead and dying cells (Figure 4). This function 
is part of the innate immune system, meaning it is non-selective, and fast working. 
Indeed, the first macrophages are recruited on the inflammation site in a matter of 
minutes. The M1 macrophages will produce high levels of Th1 chemoattractant IFNγ, 
reinforced by its own feedback loop, involving the master cytokine TNFα, IL-6 and 
IL-12. Generally, LPS sensing through Toll-Like Receptor 4 (TLR4) results in this 
inflammatory cascade, where enhanced phagocytosis, nitric oxide synthase (NOS2) 
and interleukin 1 β (IL-1β) secretion lead to further macrophage and neutrophil 
recruitment. The M1 macrophages are also antigen presenting cells and help creating 
the bridge between innate and adaptive immunity; the display of the antigen on the 
membrane will activate Th cell which in turn will activate B cells, allowing selective 
target of the antigen by antibodies. Here, a variety of intracellular and extracellular 
markers are considered (inflammatory chemokines) as well as surface markers to 
characterize the AM polarization through several stimuli. 
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Figure 4. Overview of the phagocytosis. Bacterium are engulfed and digested by the 
macrophage via phagocytosis. Remains of the bacterium are excreted and/or presented at the 
surface of the macrophage. Adapted from [24]. 
 
4.1.2. M2(a-b-c): The alternative activation 
At the cornerstone of immunity, macrophages are extremely versatile and dynamic in 
their pathogen responses. In the same way, M1 macrophages are polarized within the 
Th1 response. M2 macrophages (or alternatively activated macrophages) participate 
in the resolution of the inflammation [23,25], where they are involved in wound 
healing, repair and remodeling, when the organism returns to its homeostasis. They 
fundamentally work to reestablish homeostasis [26] by secreting anti-inflammatory 
cytokines (i.e. IL-10) and clearing the tissues from apoptotic neutrophils. M2 
macrophages are themselves subdivided in three subtypes [27]; M2a (IL-4 and/or IL-
13 stimulated macrophages), M2b (immune complexes, LPS and IL-1β activated) or 
M2c (IL-10, transforming growth factor β (TGF-β) or glucocorticoid activated) 
(Figure 3) [7,28]. Like M1 macrophages, M2 macrophages polarization is associated 
with distinctive gene signatures. 
M2a macrophages are activated by IL-4/13, mainly produced by Th2 cells. Following 
IL-4/13 binding, a downregulation of pro-inflammatory mediators (IL-6, IL-8, and IL-
12) is observed, in addition to an upregulation of C-type membrane lectins (i.e. 
MRC1), and scavenger receptors (LDL oxidation), which in turn activate Arginase 1 
production, effectively blocking NOS2 expression. 
M2b cells, activated by opsonized complexes (Fc antibody receptor binding) and 
LPS/IL-1β through TLR4 signaling, not unlike M1 macrophages. They are 
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characterized by high IL-10 and low IL-12 production. However, M2b produce also a 
significant number of inflammatory cytokines such as TNFα, IL-1β and IL-6. 
M2c comprise cells stimulated with IL-10, TGF-β, or glucocorticoids, this subtype is 
often referred to as deactivated or anti-inflammatory helps to decrease further the 
inflammation and improve tissue repair and remodeling by producing large amounts 
of IL-10 and TGF-β. During the inflammation resolution phase, a nuclear hormone, 
the “Peroxisome Proliferator Activated Receptors γ” (PPARγ) plays a key role in 
numerous immune cells, including macrophages, lymphocytes, and dendritic cells [29] 
by inhibiting inflammatory signaling through NF-κB, favoring the alternative 
polarization of macrophages. 
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4.2. Alveolar macrophages: Guardians of the lung 
homeostasis 
Macrophages are specialized hematopoietic cells, and, in the lung, the AM represent 
more than 95% of the resident leukocytes in the alveoli of a healthy human 
individual. They migrate shortly after birth to the lungs and originate from fetal 
monocytes [30] after GM-CSF differentiation [31]. It is understood that they are not 
recruited from circulating monocytes like most tissue macrophages, generated from a 
common bone marrow progenitor [32]. The AM reside on the lung epithelium at the 
interface between the environment and the host [33,34]. Thus the AM are in the lung 
frontline during bacterial infections and the first responders during inflammation [35]. 
The AM participate in several key functions allowing the lung homeostasis, such as 
phagocytosis of pathogens, clearance of apoptotic and necrotic cells; repair and 
remodeling during the resolution phase of the inflammation; and Th cells response 
promotion [36]. Macrophages polarize into different subtypes depending on the 
stimulus and the response needed [37], each subtype being specialized in a distinct 
response function. Naive (or unpolarized) AM are recognized by distinctive markers 
on their surface, making them distinguishable from interstitial macrophages or other 
resident macrophages [34,38]. The markers CD11c, CD11b, SIGLEC-F or MRC1 are 
expressed on the AM at different levels during inflammation or quiescence of the lung 
[34,39] and can be used to discriminate the mouse pulmonary macrophages. 
 
5. Th cells: role and differentiation 
T helper (Th) CD4+ cells play an important role in the adaptive immune system. 
They help the other lymphocyte to increase or decrease their activity during the 
different phases of the immune response. Through their cytokine secretion, they 
regulate B cells maturation, cytotoxic T cells activation and macrophages 
phagocytosis. T cells acquire maturity in the thymus, prior to migrating to the body. 
Naive T cells are presenting their first antigen during an immune response by a 
professional APC. Following this encounter, and after a two steps verification, T cells 
differentiate into one of many different subsets. During this study, the focus was on 
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two Th cells “couples”: the first discovered Th1/Th2 subset [40] as well as the 
Th17/Regulatory T cells (Tregs) subset more recently highlighted [41]. The return to 
homeostasis after an immune response is guaranteed by regulation of the balance 
between the pro-inflammatory and anti-inflammatory T cells. 
 
5.1. Th1/Th2 paradigm 
The Th1/Th2 paradigm is used to explain the complementary roles of these cells. Th1 
cells are triggered and efficient in the event of a replication of intracellular pathogens, 
whereas Th2 are specified against parasites and help tissue repair. Upon antigen 
presentation, the autocrine IL-12 secretion, which is reinforced by an auto feedback 
loop, leads to the differentiation of Th0 cells into Th1 or Th2, whether a cellular or 
humoral response is needed. Th1 cell’s effector cytokines are interferon gamma 
(IFNγ) and IL-2, controlled by their key respective transcription factors T-bet and 
“Signal Transducer and Activator of Transcription 4” (STAT4) [42]. IFNγ is used by 
Th1 cells to activate macrophages’ phagocytosis, and digestion and to kill 
intracellular pathogens through NOx radical production [43]. 
On the other hand, Th2 cells are triggered by IL-4 and IL-2 through STAT6 and 
GATA3 transcription factors signaling [44]. Th2 will then secrete a variety of 
cytokines (IL-4, IL-5, IL-9, IL-10, IL-13 and IL-25). IL-4 will increase Th2 
differentiation due to its positive feedback loop, stimulating in turn B cells and IgE 
production. IL-10 secretion will reduce IL-2 and IFNγ production in other Th cells. 
5.2. Th17/Tregs paradigm 
The Th1/Th2 paradigm, first proposed by Mosmann and Coffman [45], opened the 
door to modern immunology. However, this model was incomplete [46]. Other T cells 
are also responsible for the regulation of the immune system; Th17 and Tregs are 
issued from a developmentally distinct lineage from Th1/2 cells. Th17 cells are 
associated with pathogens clearance as part of the adaptive immune system. Their 
phenotype is acquired after IL-23 stimulation and characterized by their IL-17 
cytokine production. This protein is notably involved in many inflammatory 
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responses. However, uncontrolled or persistent immune responses are difficult issues 
for the organism, causing inflammatory or autoimmune diseases. Regulatory T cells 
(Tregs) tackle this by being a crucial mediator in controlling immunity and self-
tolerance. Tregs function is regulated by the transcription factor Foxp3 [47,48] leading 
to the suppression of T cell proliferation, and the inactivation of dendritic cells (DCs) 
[49,50]. 
The immune response is tightly regulated with positive and negative feedback loops, 
allowing a tailored reaction by the organism before and long after an injury. 
 
6. Lung injury and inflammation 
The inflammation is one of the first biological manifestation of the innate immune 
system when subjected to an injury or an infection. It includes, as described 
previously, an activation of complement, as well as a leucocyte recruitment and the 
antigen presentation from the professional APCs. 
Two types of injuries are generally described; acute and chronic. Together they cover 
the inflammation spectrum. Chronic Obstructive Pulmonary Disease (COPD), 
asthma and Idiopathic Pulmonary Fibrosis (IPF) are part of the chronic lung 
diseases. A bacterial infection, or a contact with pollutants initiate an acute response 
in the form of an inflammation. The consequences of “Acute Lung Injury” (ALI) will 
be further discussed here. The speed of the organism’s response is the key, relying 
mostly on innate immunity reactions. One prominent pro-inflammatory signaling 
pathway is for example the nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) cascade, which is known to be triggered by the activation of 
LPS/TLR4 and/or IFNγ receptors. Subsequently, this leads to the production and 
expression of pro-inflammatory cytokines such as TNFα, IL-1β, IL-6 and IL-12. After 
phosphorylation and translocation of the transcription factor subunits, the following 
nucleus transfer will induce DNA binding and the expression of M1 macrophages’ 
“signature genes” Nos2 and Tnf (Figure 3). 
After the inflammation response, different actors restore the homeostasis. IL-4 and 
IL-13 are binding on their receptors at M2 macrophages, which leads to the 
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expression of M2 “signature genes”, such as Arg1 and Mrc1 downstream of the 
JAK/STAT-6 axis (Figure 3 and Figure 5). 
During this whole study, the inflammation was triggered solely by LPS, a well 
described model of acute inflammation [51,52]. It allowed a fast onset, typically 
within half an hour and a fast resolution within 48-72h during in vitro as well as in 
vivo experiments. 
 
 
Figure 5. Signaling pathways of macrophage polarization [53]. Illustration of M1 and 
M2 signaling pathways interconnection, showing both the initiation and the resolution of an 
inflammation. 
NOS2: Nitric oxide synthase 2 (NOS2) catalyzes L-arginine to produce nitric oxide (NO). 
NO is one of the major resources of oxidative stress. 
Signal transducer and activator of transcription 1 (STAT1), Interferon regulatory factor 5 
(IRF5), Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and 
Activator protein 1 (AP-1), are transcription factors playing keys roles in many gene 
expressions that cause survival of the cell, viability or pathogen response. They are the 
central regulators of the inflammatory response. 
Signal transducer and activator of transcription 6 (STAT6), Interferon regulatory factor 4 
(IRF4), Peroxisome proliferator-activated receptor gamma (PPARγ ), and cAMP response 
element-binding protein (CREB) are transcription factors involved in the regulation of many 
pathologic features of inflammatory responses. They include the promotion of the 
proliferation, survival, and regulation of T and B lymphocytes as well as specific anti-
inflammatory cytokine mediated expression. 
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7. The Aryl hydrocarbon Receptor (AhR) and the immune 
system 
The “Aryl hydrocarbon Receptor” (AhR), previously known as the dioxin receptor, is 
a ligand activated transcription factor involved in the adaptive response. It binds to a 
variety of ligands, its pocket fitting environmental xenobiotics (pollutants), possessing 
polycyclic aromatic hydrocarbon or halogenated aromatic hydrocarbon structures 
[54]. 
The immunomodulatory AhR function is versatile and depends highly on the ligand 
interacting with it. Duarte et al. [55] previously showed that the binding of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) reduced IL-17 production by the inhibited 
differentiation of Th17 cells. Other agonists, such as antiallergic drugs, have been 
shown to influence Th1/Th2 balance through AhR signaling [56]. 
It is now well established that the host-microbiome mutualism is a key to the 
organism’s overall fitness [57]. This project is focused on the crosstalk effect of 
bacterial molecules with the immune system during homeostasis and inflammation. 
The immunomodulatory role of the Th1/Th2 and Th17/Tregs balances as well as their 
roles in wound healing [58] was studied to get insights into possible modulations of 
underlying mechanisms by bacterial signaling compounds. 
 
8. The lung microbiome 
Ambient air does not only carry oxygen to the body but also particles and pollutants 
as well as microbes. The smaller the exogenous body, the deeper it penetrates into 
the lung. Given the great amount of air inhaled, the cumulated concentration of the 
substances in the lung is not negligible and is suggested to worsen pulmonary 
functions, which in turn could influence other organs systemically. 
Surprisingly, the lung, as one of the gate keepers of immunity, and the interaction 
with its microbiome have been rather poorly studied. The current microbiome 
research focuses more e.g. on the gastro-intestinal tract, the skin, the urogenital 
system and the upper pulmonary system. However, recent publications have been 
showing the important role played by microbes (bacteria, fungi, viruses and phages) 
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on the dynamics of lung diseases (i.e. asthma [59], transplantations [60], cystic 
fibrosis [61]) as well as in the homeostasis of healthy individuals. The lung 
microbiome is unique to the individual; it is diverse, and varies over time [62,63]. It 
consists mostly in Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria in 
healthy individuals [64]. However, the dual role played by these commensal bacteria 
and their interaction with the host immune system remains poorly understood. A 
potential therapeutic effect of probiotic bacteria and their signaling molecules was 
hypothesized and already partly uncovered for immune diseases including chronic and 
acute lung diseases [63–68]. 
Within the biofilms formed by bacteria, cellular communication networks are created. 
The molecules involved are either N-Acyl homoserine lactones of Gram-negative 
bacteria, and e.g. D-amino acids of Gram-positive bacteria. The cross talk between 
pathogenic bacteria and the immune system via the epithelium appeared to be 
critical for patients with lung diseases [69], where quorum sensing molecules such as 
the 3-oxo-C12-HSL autoinducer seem to be key players in the severity of the disease 
by modulating various immune responses. On the other hand, the role of D-
tryptophan of probiotic Lactobacilli in beneficial interactions is just getting started to 
be understood [67]. 
 
8.1. Pseudomonas aeruginosa and the quorum sensing 
compounds N-Acyl homoserine lactones 
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen, well known to 
worsen lung function and mortality in patients with cystic fibrosis [69]. In addition, it 
is also recognized as a relevant pathogen during acute exacerbations of “Chronic 
Obstructive Pulmonary Disease” (COPD). Its pathogenicity is controlled through the 
production of quorum sensing molecules [70] such as the “N-Acyl homoserine 
lactones” (AHL), which control transcription of specific virulence genes. The quorum 
sensing (QS) is the auto-regulation phenomenon [71] used by bacteria to enable self 
and neighbor communication. The expression of the Pseudomonas aeruginosa 3-oxo-
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C12-HSL autoinducer is controlled through two [transcriptional regulation 
protein/autoinducer enzyme] couples: [RhlR/RhlI] and [LasR/LasI] [72,73]. The AHL-
signaling compounds were shown to directly interfere with the host’s immune 
responses [74–76]. 
Understanding the crosstalk of AHL signal molecules with barrier organs and the 
immune system could enable the development of immune modulatory strategies [77] 
for treatment of inflammatory lung diseases [78]. 
 
Figure 6. N-Acyl homoserine lactones. (A) 3-oxo-C12-HSL, found in e.g. 
Pseudomonas aeruginosa, Pseudomonas putida, Yersinia enterocolitica (B) 3-oxo-C4-HSL, 
synthetic AHL possessing the 3-oxo moiety and a short alkyl chain (C) C12-HSL, found in 
the Acidithiobacillus ferrooxidans, Sinorhizobium meliloti, do not possess the 3-oxo moiety. 
 
Early studies have linked the 3-oxo-C12-HSL auto-inducer to cell apoptosis and 
cytotoxicity. Shiner et al. [79] showed that 3-oxo-C12-HSL (100 μM) induced 
apoptosis in murine fibroblasts, and in human mesenchymal stem cells [80]. Tateda et 
al. described the cytotoxicity of 3-oxo-C12-HSL towards murine bone-marine derived 
macrophages, neutrophils and monocytic cell lines [81]. Furthermore, Vikström et al. 
indicated that the 3-oxo-C12-HSL triggered the alteration of junction protein causing 
a disruption in epithelial barrier function and integrity [82,83]. 
Since more than ten years, the immunomodulatory effects of quorum sensing have 
been studied. Cytokine signaling can be altered by 3-oxo-C12-HSL. Smith et al. [84] 
discovered that 3-oxo-C12-HSL increased both IL-8 production and expression in in 
human epithelial and fibroblast cells, whereas IL-2 secretion was inhibited [74]. 
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Recruitment of immune cells (such as neutrophils and macrophages) and growth of 
cell population are also affected by 3-oxo-C12-HSL treatment [85,86]. T cell 
proliferation [74] and Th1/Th2 cells differentiation were inhibited with a 3-oxo-C12-
HSL concentration as low as 18 μM [87]. These results extend the findings of 
Zimmermann et al. [75,88], describing an increased chemotaxis and phagocytosis of 
neutrophils after 3-oxo-C12-HSL treatment. Kravchenko et al. explained the 
macrophages immunomodulation by the disruption of an TLR-independent NF-κB 
signaling [89,90]. This effect may be related to the ability of 3-oxo-C12-HSL to 
function as a PPARγ agonist [76,91]. However, the immune mechanisms involved 
after 3-oxo-C12-HSL exposition as well as the target receptor within host cells are not 
yet fully resolved. However, evidence from Maurer et al. recently suggested that 3-
oxo-C12-HSL activates the expression of the surface receptor T2R38 [92]. 
In this study, 3-oxo-C4-HSL and C12-HSL act as controls for 3-oxo-C12-HSL which is 
immunologically active. They mimic the 3-oxo moiety and the alkyl chain length of 
the 3-oxo-C12-HSL, while both possessing the lactone ring (Figure 6). Indeed, it is 
speculated that only the combination of the oxo moiety with the lactone ring enables 
an immunomodulatory function. The three lactones are degraded into biologically 
inactive opened ring structure at neutral pH or slightly alkaline solution, with a half-
life of approximately 10 hours [78]. In plants having only an innate immune system, 
AHLs interfere with several biological systems, inhibiting or promoting root growth, 
as well as priming resistance against pathogens [93,94]. 
 
8.2. The inflammatory response triggered by microbes 
Gram-negative bacteria’s outer cell wall contains to an important part LPS, 
phospholipids and proteins. The endotoxin LPS is one of the most described 
“Pathogen Associated Molecular Pattern” (PAMP): it activates several “Antigen 
Presenting Cells” APCs such as monocytes, macrophages, DCs and B cells, and is 
predominantly responsible for the inflammatory response during bacterial infection 
[95]. In mammals, pathogens are first recognized by the innate immune system 
through several mechanisms including specific recognition and signal transduction, 
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followed by the adaptive immune system. The classical pathways include different 
strategies used to fight back infection and restore homeostasis. “Toll-Like Receptors” 
(TLRs) are the most studied classes of “Pattern Recognition Receptors” (PRRs); they 
possess a ligand binding domain able to recognize a variety of pathogens, such as 
bacteria, fungi or viruses. 10 subtypes or TLRs have been described, each specializing 
in a type of PAMPs [5]. The “Retinoid Acid-Inducible Gene I (RIG-I)-Like Receptors” 
(RLRs) and “Nucleotide-Binding Oligomerization Domain (NOD)-Like Receptors” 
(NLRs) are PRRs involved in the intracellular immune activation and the recognition 
of foreign nucleotides. The activation of the PRRs drives the NF- κB dependent 
inflammatory cascade, leading to production and release of the pro-inflammatory 
master cytokines tumor necrosis factor alpha (TNFα), and interleukin 1 beta (IL-1ß) 
from the cell, effectively inducing neutrophil maturation and chemotaxis.  
The Pseudomonas aeruginosa 3-oxo-C12-HSL autoinducer has been shown among 
other effects to accelerate apoptosis in macrophages and neutrophils [81] and inhibit 
DNA binding to the PPARγ. These interferences of the immune responses result from 
the upstream activation of T2R38 receptor and inhibition of NF-κB pathways [96].  
 
8.3. Lactobacillus casei and D-tryptophan 
Kepert et al. [67], analyzed immunomodulatory effects on dendritic cell maturation in 
the supernatant of probiotic Gram-positive Lactobacillus spp., Lactobacillus 
rhamnosus GG and Lactobacillus casei W56 shared the secretion of the unusual 
amino acid D-tryptophan (D-Trp). After purification, MS- and NMR-confirmation 
analysis, D-Trp was confirmed as newly identified immunomodulatory probiotic 
substance [67]. 
Both L-tryptophan (Figure 7) and D-tryptophan (D-Trp) are amino acids of 
bacterial/fungal origin secreted by several probiotic bacterial strains [67]. 
Catabolizing enzymes (e.g. indoleamine-2,3-dioxygenase - IDO) participating in Trp 
degradation, are found in cells of the immune system. It is not clear yet, which role 
D/L-Trp metabolites play in detail [66,97]. However, evidence are in favor of either a 
suppressing effect of T-cell proliferation by these metabolites, or of a more general 
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suppression of immune cells through pro-apoptotic mechanisms [97]. Interestingly, it 
was discovered that the IDO enzyme catabolizes L-Trp as well as D-Trp [98]. 
 
Figure 7. D-tryptophan structure and similarities to other D-amino acids. 
 
9. Project outline and hypotheses 
In this project, the two aspects of the immunity were treated: 
- innate immunity by the study of macrophages activation upon AHL treatment 
- adaptive immunity and the differentiation of Th2/17, considering their 
relevance in asthma [99]. 
Specific AM polarization, upon e.g. AHL and D-Trp application, could play a key 
role in the epithelium defense and homeostasis [100,101]. D-Trp could induce immune 
tolerance, possibly driving similar modulatory effects compared to AHL [97,102,103], 
although the structures differ considerably. 
There is overwhelming evidence for the importance of the crosstalk between 
microbiome and its host. From the plants to the mammals, these important relations 
have been unevenly studied. Indeed, the mutualism of microbes with human cells in 
Imidazole ring 
INTRODUCTION 
38 
the gut is well described. However, the lung microbiome in its interaction with 
alveolar immunity remains greatly unexplored. 
This study investigated, how two types of molecules, AHL and D-tryptophan 
produced from Gram-negative and Gram-positive bacteria, respectively, interact with 
the lung structure, integrity, and immunology. Th17/Th2 differentiation, AM 
polarization, responses in wound healing, in vitro and in vivo acute lung injury, and 
the associated response pathways were examined in the alveolar compartment. 
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MATERIALS AND METHODS 
1. Materials 
1.1. Mice 
The mice used for the study on the AHL effects on Th cells (wild type Balb/c genetic 
background) were kept and bred at the Institut für Molekulare Immunologie (IMI), 
Helmholtz Zentrum München. 
The mice used in the ALI in vivo studies were wild-type C57BL/6J genetic 
background and were imported from Charles River Laboratories, and then kept at the 
institute of Lung Biology and Disease (iLBD), Helmholtz Zentrum München, 
Neuherberg, according to the national and institutional guidelines. Mice were female 
and aged from 8 to 16 weeks. After sacrifice, BALF, BAL cells, spleen and lungs were 
snap frozen and stored. 
AhR-/- and AhR-/+ (C57BL/6 Ahrtm1Bra) mice were bred and kept under the 
supervision of the Dr. Ohnmacht in the Center of Allergy and Environment (ZAUM), 
Helmholtz Zentrum München, Neuherberg. The mice used were mixed males and 
females aged from 25 to 30 weeks. 
 
1.2. Kits 
Name Company 
LightCycler® 480 SYBR Green I Master (2X conc.) Life Science 
Superscript™ II Reverse Transcriptase kit Invitrogen 
Duo set ELISA kit (CXCL1, TNFα, IL-1β, CXCL5, GM-
CSF) 
R&D Systems 
RNeasy Mini Kit Qiagen 
Giemsa and May Grünwald solutions kit Sigma-Aldrich 
RNaseOUT™ Recombinant Ribonuclease Inhibitor Invitrogen 
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dNTP Mix (10 mM each) Fermentas 
 
1.3. Chemicals 
Name Company 
3-oxo-dodecanoyle homoserine lactone Sigma-Aldrich 
3-oxo-butanoyle homoserine lactone University of Nottingham 
Dodecanoyle homoserine lactone University of Nottingham 
D-F, D-H, D-M, D-P, D-Y, D-W, L-W Sigma-Aldrich 
Acetonitrile Sigma-Aldrich 
Rosiglitazone Sigma-Aldrich 
Probenecid Sigma-Aldrich 
Dimethyl sulfoxide Sigma-Aldrich 
Entellan® mounting medium Merck Millipore 
 
1.4. Recombinant proteins and antibodies 
Name Company 
Recombinant murine IFNγ Immunotools 
Recombinant murine IL-4 IL-2, IL-6, IL-13, IL-23 Immunotools 
Lipopolysaccharides (LPS) from E. coli Sigma-Aldrich 
Anti-mouse CD3 BD Bioscience 
Anti-mouse CD28 BD Bioscience 
Anti-mouse IFNγ BD Bioscience 
Mouse TGFβ BD Bioscience 
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1.5. Buffers and solutions 
Buffer/Solution Concentration Chemical 
Wash buffer (PBS-T)  
1X 
0.05% 
PBS 
Tween 20 
PBS buffer (10X)  
137 mM 
2.7 mM 
10 mM 
2 mM 
NaCl 
KCl 
Na
2
HPO
4
 
KH2PO4 
TBE buffer (10X)  
890 mM 
890 mM 
20 mM 
Tris base 
Boric acid 
EDTA (pH=8.0) 
MH-S medium 
1X 
10% 
1% 
2 mM 
50 μM 
RPMI-1640 medium 
FBS 
Penicillin/streptomycin 
Glutamine 
β-mercaptoethanol 
LA-4 medium  
1X 
15% 
1% 
2 mM 
1% 
HAM-12 medium 
FBS 
Penicillin/streptomycin 
Glutamine 
Non-essential amino acids 
MLE-12 medium 
1X 
10% 
1% 
2 mM 
RPMI-1640 medium 
FBS 
Penicillin/streptomycin 
Glutamine 
FACS Buffer 
1X 
1% 
PBS 
BSA 
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RIPA buffer (1X)  
20 mM 
150 mM 
1 mM 
1 mM 
1% 
1% 
2.5 mM 
1 mM 
1 mM 
1μg/mL 
Tris-HCl (pH 7.5)  
NaCl  
Na
2
EDTA  
EGTA  
NP-40  
sodium deoxycholate 
sodium pyrophosphate 
β-glycerophosphate 
Na
3
VO
4 
Leupeptin 
loading buffer (2X)  
100 mM 
4% 
0.2% 
20% 
Tris pH=6.8 
SDS 
Bromophenol blue 
Glycerin 
Electrophoresis (5X 
running buffer) 
15.1 g 
94 g 
50 mL 
Tris 
Glycin 
10% SDS 
Transfer buffer(1X)  
3.02 g 
14.4 g 
200 mL 
Tris pH=8.5 
H
2
O 
Methanol 
10% PAGE (4 gels) 
Resolving 
15.9 mL 
13.3 mL 
10.0 mL 
400 μL 
400 μL 
16 μL 
H
2
O 
30% Acrylamid 
1.5 M Tris pH=8.8 
10% SDS#10% APS 
TEMED 
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10% PAGE (4 gels) 
Stacking 
13.6 mL 
3.4 mL 
2.5 mL 
200 μL 
200 μL 
20 μL 
H
2
O 
30% Acrylamid 
1 M Tris pH=6.8 
10% SDS 
10%APS 
TEMED 
Block buffer (ELISA)  
1 g 
100 mL 
BSA 
1X PBS 
Stop solution (ELISA)  0.2 M H2SO4 
RT-PCR Mix 
 
 
0.1 M 
10 mM 
1 μL 
 
0.01 mM 
RNase free H2O 
5x First Strand Buffer 
10x DTT 
20x 4dNTPmix 
RNAse inhibitor 40 U/μL 
Superscript II RT 200 
U/μL 
Random Nonamers 
 
1.6. Primer sequences 
Target 
gene 
Acc. No. Forward primer (5’-3’) Reverse primer (5’-3’) 
Actb NM_007393 TCCATCATGAAGTGTGACGT 
GAGCAATGATCTTGATCTTCA
T 
Arg1 NM_007482 GGAACCCAGAGAGAGCATGA TTTTTCCAGCAGACCAGCTT 
Ccl17 NM_011332 
TTGTGTTCGCCTGTAGTGCA
TA 
CAGGAAGTTGGTGAGCTGGTA
A 
Il6 NM_031168 GCCAGAGTCCTTCAGAGAG AGACTCTCTCCCTTCTGAGC 
Il1b NM_008361 
CAACCAACAAGTGATATTCTC
CATG 
GATCCACACTCTCCAGCTGCA 
Il12b NM_008352 GGAAGCACGGCAGCAGAATA 
AACTTGAGGGAGAAGTAGGAA
GG 
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Irf4 NM_013674 
AAAGGCAAGTTCCGAGAAGG
G 
CTCGACCAATTCCTCAAAGTC
A 
Irf5 NM_012057 GCCACCTCAGCCGTACAAG 
CTCCCAGAACGTAATCATCAG
G 
Mrc1 NM_008625 CATGAGGCTTCTCCTGCTTCT TTGCCGTCTGAACTGAGATGG 
Nfkb1 NM_008689.2 AGGAAGAAAATGGCGGAGTT GCATAAGCTTCTGGCGTTTC 
Nos2 NM_010927 CCTGTGAGACCTTTGATG CCTATATTGCTGTGGCTC 
Rela NM_009045 CTTGGCAACAGCACAGACC GAGAAGTCCATGTCCGCAAT 
Retnla NM_020509 CGAGTAAGCACAGGCAGT CCAGCTAACTATCCCTCCAC 
Tnf NM_013693 CACCACGCTCTTCTGTCT GGCTACAGGCTTGTCACTC 
Il4ra NM_001008700 TCTGCATCCCGTTGTTTTGC GCACCTGTGCATCCTGAATG 
Psmd11 NM_178616 GAATGGGCCAAATCAGAGAA TGTACTTCCACCAAAAGGGC 
Psme1 NM_011189 AGGCTTCCACACGCAGATCT ACCAGCTGCCGATAGTCACC 
Psme2 NM_001029855 CCAGATCCTCCACCCAAGGA CCGGGAGGTAGCCACACTTA 
Psme3 NM_011192 TAGCCACGATGGACTGGATG 
CACAAACACCTTGGTTCCTTG
AA 
Psma3 NM_011184.4 
TGAAGAAGGCTCCAATAAAC
GTCT 
AACGAGCATCTGCCAGCAA 
Psmb5 NM_011186.1 
TGCTCGCTAACATGGTGTAT
CAGTA 
GGCCTCTCTTATCCCAGCCA 
Psmb6 NM_008946.4 
AGACGCTGTCACTTACCAACT
TGG 
AAGAGACTGGCGGCTGTGTG 
Psmb7 NM_011187.1 
TGCCTTATGTCACCATGGGT
TC 
TTCCTCCTCCATATCTGGCCTA
A 
Psmb8 NM_010724 
TGCTTATGCTACCCACAGAG
ACAA 
TTCACTTTCACCCAACCGTC 
Psmb9 NM_013585 
GTACCGTGAGGACTTGTTAG
CGC 
GGCTGTCGAATTAGCATCCCT 
Psmb10 NM_013640 GAAGACCGGTTCCAGCCAA 
CACTCAGGATCCCTGCTGTGA
T 
Csf-2 NM_009969 GCCATCAAAGAAGCCCTG 
GCGGGTCTGCACACATGTTAA
A 
Lcn2 NM_008491 GAAGAACCAAGGAGCTGT TCAATGCATTGGTCGGTG 
Tgfb NM_001013025 
TGACGTCACTGGAGTTGTAC
G 
GGTTCATGTCATGGATGGTGC 
Ccl2 NM_011331 CTTCTGGGCCTGCTGTTCA CCAGCCTACTCATTGGGATCA 
MATERIALS AND METHODS 
45 
Cx3cl1 NM_009142 GCGACAAGATGACCTCAC CCAGGTGTCACATTGTCC 
Cxcl1 NM_203320 CCGAAGTCATAGCCACAC GTGCCATCAGAGCAGTCT 
Cxcl5 NM_002994 CCCTACGGTGGAAGTCAT CTTCACTGGGGTCAGAGT 
Cxcl2 NM_002089 TCCAGAGCTTGAGTGTGACG TCCAGGTCAGTTAGCCTTGC 
Cxcl9 NM_008599 GGAGTTCGAGGAACCCTA GGGATTTGTAGTGGATCG 
Pparg NM_001127330 GTAGAAGCCGTGCAAGAG GAGGAACTCCCTGGTCAT 
Cxcr2 NM_009909 
AGCAAACACCTCTACTACCCT
CTA 
GGGCTGCATCAATTCAAATAC
CA 
Cd36 NM_001159555 
TGGAGATTACTTTTTCAGTG
CAGAA 
TCCAGCCAATGCCTTTGC 
 
2. Methods 
2.1. Alveolar macrophages (AM) cell line culture 
Murine alveolar macrophages cell line (MH-S) is derived from Balb/c mice and was 
purchased from American Type Culture Collection. Cells were grown to confluence in 
MH-S medium (RPMI-1640 medium supplemented with 10 % fetal bovine serum 
(Biochrom) and 0.05 mM β-mercaptoethanol and 100 U/ml Penicillin and 100 μg/ml 
Streptomycin (Gibco) at 37°C and 5 % CO2). When confluence was reached, the cells 
were washed twice in pre-warmed PBS at 37°C, and then 1 mL of trypsin-EDTA 
(Sigma-Aldrich) per 25 cm2 of culture was added to the flask. Cells were incubated at 
37°C, 5% CO2 for 5 min. After complete detachment, the trypsin was inactivated by 
fresh pre-warmed MH-S medium. The cells were resuspended and collected and 
centrifuged (1200 rpm, 5 min, RT). Cells were then seeded in a new flask after a 1:5 
dilution or used directly for experiments. The cells were plated according to the table 
below. MH-S cells were split twice a week. 
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Culture plate Surface area (cm2) Cells at confluency 
6-well 9 1.2x106 
12-well 4 0.4x106 
24-well 2 0.2x106 
Table 1. Cell culture experiment preparation. Relation between well plates, and 
cell density. 
 
2.2. Alveolar epithelial cell type 2 (AECII) 
Murine pneumocytes type 2 cell line (LA-4) is derived from A/He mice lung adenoma 
and was purchased from American Type Culture Collection. The subculture 
procedure is the same as described previously, with the culture media changed to the 
LA-4 culture media. 
 
2.3. Alveolar macrophages polarization 
AM were polarized in vitro towards the M1 phenotype with LPS (1 μg/mL, Sigma) 
and/or IFNγ (20 ng/mL, Immunotool) or towards the M2 phenotype with IL-4 (20 
ng/mL, Immunotool) treatment for up to 72 h. Unpolarized AM (M0) served as 
controls. Polarization was validated via quantitative RT PCR for M1 markers (Tnf, 
Il1b, and Nos2) and M2 markers (Arg1, Cxcr2, and Il10r) [104,105]. Cell culture 
supernatants were collected for γlammatory cytokines measurement. Adherent AMs 
were washed twice with PBS and harvested for mRNA isolation (Qiagen) and 
measurement of mRNA expression levels (Light Cycler 480, Roche). 
 
2.4. N-Acyl homoserine lactones (AHL) treatment 
Bacteria produce AHL in a continuous manner to determine their neighboring 
bacterial concentration (e.g. quorum sensing). To mimic this biological process, cells 
were treated simultaneously with 3-oxo-C12-HSL, C12-HSL, 3-oxo-C4-HSL, or vehicle 
(0.6% (n=2) and 1% (n=1) DMSO) was added. The concentration of AHL used in 
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the media was 60 μM according to previous studies [78,106], which had been shown to 
be of biological relevance. Cells and supernatants were harvested after 6h (n=1), 24h 
(n=3), or 72h (n=1) of treatment. 
 
2.5. AECII/AM single well coculture 
LA-4 (or MLE-12) cells were seeded on the first day, following the density 
recommended in Table 1. After incubating overnight in the standard conditions, MH-
S were added on the top of the LA-4 monolayer respecting a final cell ratio of 
1:3 (MH-S:LA-4) in a 1:1 medium mix. After another overnight incubation, the cells 
were treated. 
 
2.6. AECII/AM/Pseudomonas aeruginosa (PAO1) 
transwell culture 
Murine cells were grown on the bottom well following the same procedure as 
explained in 2.5. PAO1 were cultivated for the last 24h in the same 1:1 media as the 
murine cells at the concentration 106 CFU/mL. 0.5x106 PAO1 were added on the 
transwell (Becton Dickinson Labware) above the AECII/AM layer. QS-molecules 
treatment was added in the transwell to allow molecular diffusion to the murine cell 
layer in the bottom well. 
 
2.7. AECII/PAO1 supernatant culture wound healing 
assay 
Murine AECII (LA-4) were plated on 24-well plates and then let at rest overnight. 
The cells were scratched, gently rinsed with PBS and covered by 1 mL of PAO1 
bacterial free supernatant/LA-4 medium (1:1). The cells were incubated 24h under 
normal conditions as previously described in 2.1. The area of the wound was 
measured by light microscopy directly after its creation and 24h after. 
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2.8. Intratracheal instillation 
2.8.1. Acute Lung Injury (ALI) 
ALI is modeled by the inhalation of a suspension of LPS particles (2 μg/mL, 50 μL) 
in the mouse trachea to create an acute inflammation of the lungs characterized by 
leucocytes infiltration, increased blood barrier permeability and massive cytokine 
release. To assess the therapeutic anti-inflammatory potential of AHL and D-Trp 
during an ALI, 8 weeks old C57BL/6J mice were anesthetized with MMF (2.5 μL/g) 
and intratracheally instilled. The lungs and BALF were harvested for analysis after 
24 or 48h after initial LPS instillation. The mice were then woken up with MMF 
antagonist (10 μL/g) and let to rest for 6 hours. 
 
2.8.2. D-Trp/AHL Treatments 
The mice were anesthetized following the same protocol as in 2.8.1 and then treated 
with 50 μL PBS, AHL (300-1200 μM dissolved in ACN and diluted in PBS) or D-Trp 
(100 μM-50 mM dissolved and diluted in PBS). The mice were then woken up with 
MMF antagonist (15 μL/g) and let to rest. 24h later, the lungs were washed to collect 
the BALF and cells, and the lungs were harvested. 
 
2.9. BAL analysis 
2.9.1. Cytospins slides generation 
BAL cells were centrifuged and resuspended in 1 mL of cold PBS. The cells 
concentration was obtained counting the cells with a Neubauer counting chamber. A 
variable volume (100-200 μL) containing 30 000 cells is then loaded on the Cytospin. 
The cells are centrifuged on the Cytospin 400rpm 6 min at 400 rpm. The slides are 
then dried at room temperature for an hour. The slides are then either frozen at 
-80°C or stained directly. 
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2.9.2. May-Grünwald-Giemsa staining 
A dilution in water 1:5 of Giemsa solution is prepared. The dried Cytospin slides are 
soaked consecutively 10 min in May-Grünwald solution, then 2 min in water, followed 
by 15 min in diluted Giemsa and finally in water for an additional 2 min. The slides 
are then dried for one hour and then covered with Entellan® and mounted with 
cover slips. The total number of cells visible on the slide is then counted with the 
help of a microscope (bright field). 
 
2.10. Enzyme-Linked Immunosorbent Assay (ELISA) 
Cell supernatant or BAL cytokine content was snap-frozen and kept at -80°C until 
analysis. Concentrations were measured via spectrophotometry (Tecan-Magellan™) 
using ELISA kits (Duoset Detection Kit; R&D Systems) according to the 
manufacturer’s instruction. The standard curve was set using dilutions of the 
recombinant protein of interest. The detection limits were comprised between 3.9 and 
60 pg/mL depending on the assay. 
 
2.11. Cell viability assay with Water Soluble Tetrazolium 
salt (WST) 
The WST-1 kit used contains a light sensitive electron-coupling reagent diluted in 
PBS. The principle of the assay is the reduction of the tetrazolium salt to formazan 
by metabolic active cells [107]. More viable cells directly translate to more activity of 
the mitochondrial succinate dehydrogenase; which leads to an increase of the dye 
formazan. The quantification of the dye is measured by light spectrometry. 
The procedure was performed in 96-well plates. The wells were plated in advance 
with a cell concentration of 250 000 cells per well. At the time of the experiment, a 
final volume of 100 μL of reagent diluted to its working dilution (1:10) is added to the 
cells and incubated 15 min at 37°C. The absorbance of the samples was measured 
against a background control as blank using a microplate reader at =450 nm. 
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2.12. RNA isolation 
The RNA isolation from cell lysate was conducted according to the RNeasy Mini Kit 
instruction manual (Qiagen). The RNA quality and concentration were controlled at 
260 nm by spectrophotometric analysis (Nanodrop 2000, Thermo Scientific). 
 
2.13. Reverse Transcription of total mRNA 
The reverse transcription was conducted using 1 μg of mRNA. The cDNA synthesis 
was performed following the Invitrogen guidelines (cf. Buffers and solutions). 10 μL of 
mRNA template and 1 μL of Nonamers were heated 5 min at 70°C then cooled on ice 
for 5 min. The RT-PCR mix was then added to the samples and incubated 1 hour at 
42°C. The enzyme was inactivated in a final step (15 min at 70°C). The samples were 
then diluted down 1:5 before -20°C storage. 
 
2.14. Transcriptome analysis – Quantitative PCR 
cDNA synthesis was conducted following the Invitrogen guidelines. mRNA 
quantification was measured by real time quantitative PCR (qPCR) (Roche, 
LightCycler®) after 45 cycles using the TaqMan SYBR green PCR master mix. The 
used primer sets are summarized in Methods 1.6. The fold change in expression of 
each target gene relative to Hypoxanthine-guanine phosphoribosyl transferase (Hprt, 
murine cells) was calculated based on the threshold cycle (Ct) where the Normalized 
Relative Quantity (NRQ) is expressed: 2-ΔCt, where ΔCt = Cttarget gene – CtHprt. 
 
2.15. Lung homogenate preparation 
After dissection, the lung lobes were snap frozen in liquid nitrogen, then powdered 
using a micro-dismembrator (Sartorius). The lung homogenate was then dissolved in 
RIPA for protein analysis or in Qiazol® for mRNA isolation. 
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2.16. Th cells isolation and differentiation 
Naive CD4+ T cells were harvested from Balb/c mice spleen (6-8 weeks, WT, 
Institute for Molecular Immunology), and isolated via CD4+ positive selection or 
negative depletion with MACS® magnetic beads technology (Miltenyi Biotec). They 
were differentiated to Th2 cells using IL-2/-4 or Th17 cells using IL-6/-23 and TGFβ1 
in a medium containing the anti-CD3/CD28/IFNγ antibodies. Differentiation was 
confirmed via qPCR (Gata3 for Th2 and Rorc for Th17). Th2 and Th17 cells were 
cultivated for 72h and 96h respectively with P. aeruginosa’s active AHL (3-oxo-C12-
HSL) or controls (3-oxo-C4-HSL, C12-HSL, and DMSO) at concentrations ranging 
from 5 to 100 μM.  
 
2.17. FACS analysis 
2.17.1. IL-4/17 
The primary Th cells previously and freshly isolated were activated with PMA 
(50 ng/mL)/Ionomycin (1 μg/mL) during 5h (37°C, 5% CO2). CD4 external receptors 
were stained first by anti-CD4 Ab and incubated 25 min at 4°C. The cells were then 
fixed with cytofix/cytoperm™ (BD Biosciences) following the manufacturer’s 
instructions. Internal IL-4/IL-17 staining was performed with IL-4/IL-17 Ab and 
PermWash™ (BD Biosciences). The cells were then incubated 30 min at 4°C. After 
centrifugation, the supernatant was discarded, and the stained cells were kept in 
FACS buffer for a maximum of one week before FACS analysis (BD FACSCanto). 
 
2.17.2. Annexin V-PI 
Isolated cells were incubated (15 min, dark, RT) with binding buffer and AB Annexin 
V-FITC. After centrifugation and supernatant removal, PI in FACS buffer was added 
to the cells immediately prior to FACS analysis. 
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RESULTS: EFFECT OF BACTERIAL METABOLITES ON 
LUNG EPITHELIUM AND IMMUNITY 
 
In this manuscript, bacterial metabolites are subdivided in two distinct categories, 
whether they consist of N-Acyl homoserine lactone compounds originating from 
Gram-negative bacteria or the amino-acid D-tryptophan originating from the Gram-
positive bacteria Lactobacillus casei. 
 
I- EFFECT OF N-ACYL HOMOSERINE LACTONE 
COMPOUNDS OF GRAM-NEGATIVE BACTERIA ON 
LUNG EPITHELIUM AND IMMUNITY 
 
1. The quorum sensing molecule AHL modulates Th cell 
differentiation 
1.1. 3-oxo-C12-HSL increased IL-17 accumulation in Th17 
cells 
T helper cells 2 and 17 essentially participate in the etiology of atopic and non-atopic 
forms of asthma [99]. This study asked whether any of the 3 AHLs affect Th cell 
function or activation, which might in turn improve host’s health. FACS analysis 
(CD4+/IL-17+) of pre-differentiated and isolated Th17 cells, treated with 3-oxo-C12-
HSL (100 μM) showed a 2.1 and 1.5-fold increase in IL-17 production after 48 and 
96h respectively (Figure 8). It is important to note that, using our protocol, Th17 
differentiation can take up to 5 days [108]. During the stimulation of naïve T cells, 
TGF-β as well as IL-21 are required for the induction and the differentiation of Th17 
cells. Furthermore, the Th17 lineage (IL-17 producing cells), was shown to exclusively 
drive TGF-β-treated T cells to become Th17 cells [109–111]. However, the 3-oxo-C12-
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HSL did not reduce Th17 cell subset differentiation as previously described [87,112], 
but instead enhanced it without contact with an antigen presenting cell. Here the 
differentiation was only driven by cytokine and antibody stimulation (Table 2). 
 
 Differentiation cocktail 
Th17 
24h-
72h 
RPMI 
Medium 
α -CD3 
(4 μ g/mL) 
α-CD28 
(30 ng/mL) 
IL-6 
(20 ng/mL) 
IL-23 
(10 ng/mL) 
TGF-β1 
(5 ng/mL) 
α-IFNγ 
(10 μ g/mL) 
Table 2. Murine Th17 cell differentiation protocol from isolated primary naïve T 
cells 
 
Among the three AHLs used, only 3-oxo-C12-HSL which contained a lactone ring, an 
oxo-group and a long alkyl chain, increased Th17 differentiation (Figure 6). The C12-
HSL lacked the oxo function and the 3-oxo-C4-HSL had a short alkyl chain. 
Therefore, all three functional groups were needed to increase the Th17 
differentiation. 
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Figure 8. 3-oxo-C12-HSL treatment increases Th17 differentiation.FACS analysis of 
wild type mouse primary spleen CD4+ Th cells, isolated with magnetic beads and 
simultaneously polarized into Th17 and treated with AHL. (A) Quantification of 3 
independent experiments were the percentage of IL-17+ cells among all cells is shown. (B) 
The dot plots (X-axis: IL-17+ and Y-axis: CD4+) and histograms (X-axis: IL-17+ and Y-axis: 
cell count) are representing the gating of Th17 cells identified as both CD4+ and IL-17+. 
FACS representative dot blot of 3 experiments. (DMSO 1%, n=3, values represent the mean 
± SEM, *: p<0.05) 
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1.2. 3-oxo-C12-HSL did not influence Th2 cells polarization 
Th2 cell differentiation was not modulated by 3-oxo-C12-HSL treatment at any 
concentration or time point investigated. However, the 3-oxo-C12-HSL alkyl analogue 
C12-HSL (50 μM) slightly reduced IL-4 production after 48h, showing that 
substitution of the alkyl chain had some role during Th2 differentiation (Figure 9). 
However, compared to the results obtained with IL-17+ cells (Figure 8), this slight 
reduction caused by C12-HSL suggests more a minor side effect and does not appear 
to be biologically relevant towards Th2 cells differentiation. 
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Figure 9. C12-HSL treatment decreases Th2 differentiation. FACS analysis of wild 
type mouse primary spleen CD4+ Th cells, isolated with magnetic beads and simultaneously 
polarized into Th2 and treated with AHL. (A) Quantification of 3 independent experiments 
were the percentage of IL-4+ cells among all cells is shown. (B) The dot plots (X-axis: IL-4+ 
and Y-axis: CD4+) and histograms (X-axis: IL-4+ and Y-axis: cell count) are representing the 
gating of Th2 cells identified as both CD4+ and IL-4+. FACS representative dot blot of 3 
experiments. (DMSO 0.5%, n=3, values represent the mean ± SEM, *: p<0.05) 
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2. Bacterial AHL-compounds influence the innate inflammatory 
response 
The immunologic activity of “Alveolar Macrophages” (AM) provides the first line of 
defense against microbial invasion in the lower respiratory tract. The clearance 
capacity of AM further protects the fragile alveolar surface from deposited debris and 
inhaled particles. Therefore, the well-balanced plasticity of AMs is crucial for the 
maintenance of respiratory health. “Naïve” macrophages, M0 were polarized with 
LPS/IFNγ into pro-inflammatory M1 macrophages (classical activation) or with IL-4 
in anti-inflammatory M2 macrophages (alternative activation). M1 AMs do not only 
fight invading pathogens, but may also contribute to tissue damage when they 
become hyperresponsive, possibly leading to uncontrolled release of pro-inflammatory 
mediators that exacerbate acute tissue injury of infected airways [113]. In a similar 
manner, M2 polarized AM key functions include resolution of airway inflammation, 
pulmonary wound healing and anti-parasitic responses [114]. However, 
disproportionate M2 activity can also contribute to the pathology of chronic lung 
diseases characterized by an excessive Th2 response, as evidenced for allergic asthma 
or tissue remodeling for pulmonary fibrosis [115]. 
 
2.1. AHL reduces alveolar macrophages pro-inflammatory 
gene expression upon M1 polarization 
The polarization protocol significantly regulated the expression levels of certain M1 
and M2 markers depending on the type of stimulation. After 24h, LPS/IFNγ alone 
induced Tnf mRNA expression by 35 folds, whereas in combination with the 3-oxo-
C12-HSL, Tnf expression was reduced to 14 folds. Similarly, mRNAs for IL-1β (Il1b) 
and IL-10 (Il10) demonstrated a 1060-fold increase and a decrease to 1.65-fold after 
LPS/IFNγ treatment and a 500 and 1.10-fold decrease after AHL stimulation, 
respectively (Figure 10). Current data suggest that AHL treatment of LPS-treated 
AM limits TNFα, IL-1β and IL-10 cytokine production [78], thus modulating their 
inflammatory immune role. Interestingly, these results were in favor of a global AHL 
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response and not only from the 3-oxo-C12-HSL. Since only 3-oxo-C12-HSL is of 
biological relevance, it became clear that the genetic regulations were driven by a 
common feature; indeed, all three tested molecules share the lactone ring. 
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Figure 10. AHL treatment reduces LPS/IFNγ  induced Tnf and Il1b mRNA 
expression in AM. MH-S cells were analyzed 24h after AHL (60 μM)/LPS (1 μg/mL) 
treatment for mRNA expression relative to Hprt.  
M0: no polarization; M1: LPS(+)/IFNγ(+). (1% DMSO, n=3, values represent the mean 
± SEM, *: p<0.05, **: p<0.01) 
 
 
2.2. AHL signaling increases in vitro inflammatory 
cytokine production. 
To investigate whether mRNA expression is translated to protein expression in vitro, 
cell supernatants were analyzed to detect the relevant M1 cytokines secretion after 
LPS, or AHL treatment. The protein detection was realized via a protein 
immunosorbent assay (ELISA). TNFα and IL-1β’s pathways of cytokine expression 
rely both on inflammatory transcription factors (nuclear factor kappa-light-chain-
enhancer of activated B cells) NF-κB and Activator protein 1 (AP-1) and their 
related signaling. In addition IL-1b protein maturation depends on the cleavage of the 
inactive Pro-IL-1b by Caspase 1/Interleukin-1 converting enzyme, a unique two-
signal mechanism allowing a tight regulation of the release of mature IL-1β, the pro-
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inflammatory master cytokine [116]. This additional step between transcription and 
extracellular release can also explain potential differences between mRNA regulation 
observed via qPCR and protein secretion. In a similar way, TNFα needs to be cleaved 
by the metalloprotease ADAM17/tumor necrosis factor-α-converting enzyme before 
release of the transmembrane protein expressed cytokine into the intracellular space. 
The results showed a 1.4-fold increase of TNFα in the supernatant of the AM treated 
with AHL whereas baseline levels of M0 AM were not affected. Furthermore, it is 
noticeable that the dimethyl sulfoxide (DMSO) vehicle control also led to a reduction 
of TNFα and IL-1β release by the AM. Interestingly, the data obtained do not 
confirm qPCR findings (Figure 11) where a moderate decrease of Tnf, and Il1b was 
observed. This can be explained by the fact that gene expression analysis and protein 
analysis were performed at the same time point. Protein release is downstream from 
mRNA expression and translation, and it is likely that the latter already passed its 
maximum at the time of analysis. Indeed, Tnf regulations are notoriously fast and 
can return to baseline level within a day [117]. Thus, obtaining the maximum of 
TNFα secretion and mRNA expression at the same time is not feasible. 
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Figure 11. 3-oxo-C12-HSL treatment increases LPS/IFNγ induced IL-1b and 
TNFα release. MH-S cell supernatants were analyzed 24h after AHL (60 μM)/LPS 
(1 μg/mL) treatment. ELISA assay.  
M0: no polarization; M1: LPS(+)/IFNγ(+). (1% DMSO, n=3, values represent the mean ± 
SEM, *: p<0.05) 
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2.3. In vitro AHL supports M2 polarization 
AHLs triggered the pro-inflammatory cytokine TNFα secretion, hence showing that 
they both increase M1 polarization when LPS treated. Here, in the aim of showing a 
possible anti-inflammatory potency of AHLs, M2 polarization upon AHL treatment 
was measured. To this end, the gene expression of Arginase 1 (Arg1) and Mannose 
Receptor C-Type 1 (Mrc1), previously described as classic M2 markers [118], were 
measured. 
Arg1 and to some extent also Il1b displayed significant higher levels of mRNA levels 
compared to the vehicle control (DMSO) in the M2 polarized group. A moderate 
decrease of Il10 mRNA expression was also observed in the M2 polarized group 
(Figure 12). As for the M1 polarization, the changes in gene expression were not only 
limited to the 3-oxo-C12-HSL but also concerned the cell treated with 3-oxo-C4-HSL. 
This confirms previous results obtained for the Th cells, suggesting an obligate 
involvement of the lactone ring and the presence of a 3-oxo group in the pro-
inflammatory role of AHLs in the Th cell and the AM activities. 
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Figure 12. 3-oxo-C12-HSL and 3-oxo-C4-HSL treatment increases IL-4 induced 
Arg1 and Il1b mRNA levels in AM. MH-S cells were analyzed 24h after AHL 
(60 μM)/IL-4 (20 ng/mL) treatment for mRNA expression relative to Hprt.  
M0: no polarization; M2: IL-4(+). (1 % DMSO, n=3, values represent the mean ± SEM, 
*: p<0.05) 
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2.4. Dimethyl sulfoxide influences AM polarization 
AHLs are organic molecules, and precipitate in aqueous medium even at low 
concentration, essentially because of their hydrophobic alkyl chain. AHLs need to be 
dissolved in the cell medium to further interact with them. There is no consensus, 
what is the best solvent for this group of molecules. The solvent must be non-
interacting with the molecule it transports for stability reasons and relatively inert to 
the molecule’s target. 
As previously explained, dimethyl sulfoxide (to concentration up to 1%) was 
described as a solvent of choice for its biocompatibility and low toxicity [119] in drug 
testing assays particularly when facing solubility issues, dissolving easily polar and 
non-polar molecules. Considering its high diluent power towards AHL and its relative 
innocuity towards mammalian cells, DMSO was thought at first to be the vehicle of 
choice for the AHL delivery. However, the data showed that even low concentrations 
of DMSO could alter gene and protein expression (Figure 22). Meanwhile, Elisia et al. 
demonstrated in 2016 the anti-inflammatory effects of the DMSO ex vivo; 0.5% of 
DMSO in the cell medium was sufficient to reduce TNFα secretion by a factor of 1.8 
[120]. This confirms previous results of this study. Some concerns were also raised 
concerning the toxicity of the substance for AM. The acetonitrile (ACN) showed a 
better biocompatibility than DMSO as an AHL solvent (Figure 13) and was then 
used during the following experiments. A metabolic activity assay was performed, 
assessing the viability of the AM facing a DMSO or an ACN dose response. AM 
showed a greater viability from 0.1% to 10% ACN treatment, with at least 60% cell 
viability after 24h. On the other hand, as confirmed by other recent findings [120], 
DMSO treated AM displayed a greater mortality for higher doses. The 3-oxo-C12-HSL 
(dissolved in DMSO) displayed the same viability trend as the DMSO alone on the 
cells, bringing to the conclusion that DMSO had more effect on the cell viability than 
the AHL alone. Remarkably, the viability exceeds 100%, this is explained by the high 
mitosis rate of MH-S cells. Thus, in our system, ACN (0.2%) was more tolerated than 
DMSO (1%) by the AM. Consequently, for the following experiments, ACN (0.2%) 
was confirmed as vehicle solvent. 
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Figure 13. Naive AM (M0) show a greater viability on a wide range of 
concentrations when treated with ACN. Naive MH-S cells were incubated 24h with 
DMSO or ACN treatment. WST-1 assay assessed cell viability via metabolic activity. The 
results obtained are normalized to untreated AM. (n=3) 
 
3. AHL treatment on AEC/AM coculture reduces M1 
inflammatory gene expression 
The epithelial cells are the first lining of the lung epithelium. They fulfill several 
roles, from surfactant production to cell repair, and even immune functions [121,122]. 
Alveolar epithelial cells type 2 (AECII) constitute most of the respiratory surface 
area potentially interacting with QS molecules. AM/AEC interactions are responsible 
for the epithelium integrity and immunity and might also contribute for AM 
activation. Also, it has been shown that AM/AECII crosstalk during ALI was 
promoting TNFα mediated AECII proliferation via autocrine GM-CSF secretion 
[123].
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An AM/AECII coculture model was used to investigate AHL effects on AM 
polarization (MATERIALS AND METHODS, 2.5). AECII and AM were introduced 
successively in the medium cocultured overnight. AHLs (60 μM) and polarization 
medium (20 ng/mL IL-4 or 1 μg/mL LPS) were then applied to the cells 
simultaneously. 
 
 
Figure 14. Light microscopy of murine AECII (LA-4)/AM (MH-S) coculture 48h 
after plate seeding. LA-4/MH-S were respectively seeded at a 24h interval and were 
incubated at 37°C, 5% CO2. MH-S are notably smaller and rounder than the elongated LA-4 
cells. 
 
AHL treatment on AM/AEC coculture reduced Nos2, Tnf and Il1b expression by 
more than 2 folds after 3-oxo-C12-HSL (60 μM) and LPS treatment (Figure 15), 
consistent with the previous data (Figure 10) on AM monocultures. 
Rosiglitazone (RGZ) is an anti-inflammatory drug [124] from the Thiazolidinedione 
family, particularly studied as a ligand to the PPARγ receptor and its effects on 
epithelial wound healing and lung repair [125]. It has been shown by Xu et al. that 
RGZ treatment was impairing M1 polarization and more specifically TNFα expression 
[126]. Here, RGZ was used as a positive control of wound repair, since PPARγ 
activation by RGZ impairs the NF-κB pathway, reducing the M1 overall polarization. 
A robust increase in Arg1 levels in the M2 polarized group was also observed (Figure 
15 B) as well as a 120-fold increase after IL-4 stimulation, compared to a 20-fold 
increase for the ACN vehicle control. This was a strong confirmation of the anti-
inflammatory promoting effect of RGZ and 3-oxo-C12-HSL towards M2 polarization. 
These results are consistent with previous findings on gene regulations and 
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polarization of AM culture caused by AHLS. The presence of epithelial cells rose the 
background mRNA level of TNFα, reinforcing their immune role. This confirms 
previous findings of Thorley et al. [127], describing the active role of AECII during 
the immune response consisting in the expression of TLR4 and TNF-α. In essence, 
these results agree with Pechkovsky et al. [128], showing that AECII cell lines 
promoted NOS2 expression in LPS or IFNγ treated AM. 
Interestingly, the 3-oxo-C12-HSL was the only AHL which had a significant effect on 
the inflammatory genes tested. Therefore, this suggests a more complex mechanism 
linked to this specific AHL structure. 
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Figure 15. 3-oxo-C12-HSL (60 μM) treatment reduces (A) LPS induced Tnf, 
Nos2 and Il1b mRNA expression in AM/AECII coculture as well as increases 
(B) IL-4 induced Arg1 expression. MH-S/LA-4 cells were analyzed 24h after 
AHL/polarization treatment for mRNA expression relative to Hprt.  
M0: no polarization; M1: LPS(+)/IFNγ(+); M2: IL-4(+). (ACN 0.2%, n=3, values represent 
the mean ± SEM, **: p<0.01, ***: p<0.001, ****: p<0.0001) 
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4. AHL-molecules impaired epithelial barrier function and 
wound healing is independent to LPS induced acute 
inflammatory effect 
Respiratory diseases are a global burden [129], all of them lead to a certain extend of 
destruction or modification of lung structures. The alveolar epithelium represents the 
largest surface area of our body that is continual interacting with the ambient 
environment, and frequently subject to pathogen attacks [130]. Adults lungs are 
capable of moderate self-repair [131], however, extensive damage lead to loss of lung 
function and in some cases, death. Thus, the lung epithelial barrier repair after an 
injury is vital [132]. AECII cells had been shown to play a central role during alveolar 
repair [10] and innate immunity. It was hypothesized that AM and AECII worked 
conjointly towards epithelial repair. For this purpose, a coculture wound repair assay 
was set to investigate the effect of inflammation, AHLs, and cell types on wound 
healing. The model used was simulating an acute lung injury. This translated in vitro 
to a longitudinal cut through the cell bi-layer submerged in medium (MATERIALS 
AND METHODS, 2.8.1). AECII and AM were cocultured and treated with AHL 
under pro-inflammatory or normal conditions (Table 3). 
 
# 
AECII 
(LA-4/MLE-12) 
AM 
(MH-S) 
LPS 
(1μg/mL) 
AHL 
Impact of? 
(60 μM) 
1 + - - - 
Coculture 
2 + + - - 
3 + + + - Inflammation 
4 + + - + AHL 
5 + + + + 
AHL and 
inflammation 
Table 3. Summary of coculture conditions in epithelial immunity assays. 
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To measure the rate and efficiency of wound repair [133], two types of AECII (LA-4 
and MLE-12) were monitored for 48h. LA-4 and MLE-12 are two commonly used 
murine AECII cell lines; expressing most but not all the features of primary cells 
[134]. Testing various cell lines avoids to limit the results to only one cell line 
phenotype. LA-4 cells are issued from urethan-induced mouse lung adenoma. They 
are not tumorigenic but produce and release a C-type RNA virus into the culture 
medium [135]. MLE-12 cells are distal respiratory epithelial cell lines transformed by 
the oncogene SV40 Large T Antigen [136]. The responsiveness of AECII towards LPS 
(to simulate an acute lung inflammation) is subject to controversy [121,127]. 
An acute inflammation assay was performed consisting in AHL/LPS co-stimulation 
on an AECII monolayer. The monolayer of the control group was completely repaired 
48h after the scratch (100% cell density), thus 48h was decided as the endpoint. The 
3-oxo-C12-HSL treatment resulted in optically greater mortality (i.e. greater cell 
detachment from the well) and fewer repair of the wound for both cell lines (Figure 
16 and Figure 17). These findings did not support a pro-resolving effect of the AHL 
on inflammation. A similar previous work on Caco-2 cells showed that the 3-oxo-C12-
HSL was disrupting tight junctions of the intestinal wall [83]. These results could be 
extended to other epithelial cell lines such as LA-4. Interestingly, the same results 
were observed in the presence and the absence of LPS treatment (Figure 16), 
indicating that the epithelial repair is not TLR4 dependent in our setup. The 
presence of AM in the coculture experiment did not have a beneficial effect on the 
repair (Figure 17). 
Remarkably, wound closure impairment was only observed for the cells stimulated 
with the 3-oxo-C12-HSL (Figure 17). This may be explained by the presence of a 
specific receptor for 3-oxo-C12-HSL on AECII [96]. RGZ did not increase the repair 
speed of the AECII monolayer; this could be due to its poor solubility in ACN, as 
some fine crystalline precipitate was observed in the well. 
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Figure 16. 3-oxo-C12-HSL impairs wound repair of AECII monolayer. Light 
microscopy of LA-4 cells cultivated from 0 to 48h after scratch and (A) LPS (1 mg/mL), (B) 
3-oxo-C12-HSL (60 μM)/LPS (1 mg/mL), (C) RGZ (60 μM)/LPS (1 mg/mL), (D) no 
treatment control, (E) 3-oxo-C12-HSL (60 μM), and (F) RGZ (60 μM). Wound surfaces were 
determined 0 and 24 hours after wounding. 
RESULTS 
68 
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
SL
R
G
Z
0
20
40
60
80
100
****
LA-4/MH-S/AHLA
ACN
3-oxo-C12-HSL
3-oxo-C4-HSL
C12-HSL
RGZ
LA-4/AHL
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
SL
R
G
Z
0
20
40
60
80
100
**
B
ACN
3-oxo-C12-HSL
3-oxo-C4-HSL
C12-HSL
RGZ
MLE-12/MH-S/AHL
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
SL
R
G
Z
0
50
100
%
 w
o
u
n
d
 c
lo
s
u
re *
ACN
3-oxo-C12-HSL
3-oxo-C4-HSL
C12-HSL
RGZ
C
 
Figure 17. 3-oxo-C12-HSL selectively impairs wound closure of AECII monolayer 
and AECII/AM coculture. (A) LA-4/MH-S (B) LA-4 (C) MLE-12/MH-S cells were 
cultivated from 0 to 24h after simultaneous scratch and treatment with ACN (0.6%)/3-oxo-
C12-HSL (60 μM)/3-oxo-C4-HSL (60 μM)/C12-HSL (60 μM)/RGZ (60 μM). Wound widths 
were determined 0 and 24 hours after wounding. (n=7, values represent the mean ± SEM, *: 
p<0.05) 
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5. P. aeruginosa PAO1 supernatant impairs epithelial wound 
healing independently to 3-oxo-C12-HSL 
Initial hypotheses and results postulated the AHL as the mediator of wound repair 
impairment and mRNA pro-inflammatory gene deregulator. However, Pseudomonas 
aeruginosa signaling consists in more than just AHL-dependent virulence regulating, 
QS-systems. PAO1 QS systems are also controlled by the pqsA-E operon for the 
biosynthesis of 2-alkyl-4(1H)-quinolone (AQ) molecules [137]. AQ signaling is not part 
of the scope of this study. PAO1 consists in two AHL dependent quorum-sensing 
virulence systems (Las and Rhl); LasI being responsible for the synthesis of the 
autoinducer 3-oxo-C12-HSL, and RhlI directing the synthesis of the C4-HSL [138]. To 
investigate the selective effect of the 3-oxo-C12-HSL on the epithelium, in addition to 
the wild type strain, two PAO1 mutant strains were used; Las KO and Rhl KO, 
silencing their respective autoinducers. The mutant strains were obtained by the 
team of the Dr. Rothballer (Molecular Microbial Ecology, Helmholtz Zentrum 
München) from the construct developed by Wilder et al. [139]. The supernatant from 
the wild and mutant strains were sterile filtered and used to treat AECII/AM 
cultures ongoing a wound healing assay. Prior to the experiment, wild type PAO1 
supernatant was analyzed and a 3-oxo-C12-HSL concentration of 17 μM was 
measured. Consistently with these findings, LA-4 cells were treated with 20 μM 3-
oxo-C12-HSL in a 1:1 PAO1:LA-4 medium. 
In a previous study, Wu et al. showed that PAO1 cell-free supernatant had the same 
effect on AECII (A549 cell line) as LPS (200 ng/mL) treatment [140] which lead to 
25% of cell death. Here, as explained above, LPS did not significantly influence the 
wound repair of LA-4 or MLE-12 cells. However, all the PAO1 supernatants resulted 
in the almost complete destruction of the epithelial cell layer surrounding the wound. 
This deleterious effect on wound healing was stronger than any other 3-oxo-C12-HSL 
concentration (Figure 18). The wounded area ended being unquantifiable for both 
mutant bacterial strains. Thus, this suggested that the wound healing dynamics were 
not modified by 3-oxo-C12-HSL and depended on other factors present in WT/KO 
PAO1 supernatant of Las KO and Rhl KO mutants of PAO1.
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Indeed, cytotoxic and degradative bacterial enzymes can survive sterile filtration and 
can cause DNA damage as well as cell death [141] Yet, the results (Figure 18) suggest 
a threshold between 20 and 60 μM where 3-oxo-C12-HSL alone actively impairs the 
epithelial repair. 
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Figure 18. PAO1 supernatant and 3-oxo-C12-HSL impairs epithelial wound 
closure of AECII monolayer. LA-4 cells were cultivated from 0 to 24h after simultaneous 
scratch and treatment with ACN (0.6%)/PAO1 Las KO supernatant/PAO1 Rhl KO 
supernatant/PAO1 WT supernatant/3-oxo-C12-HSL (20-60 μM). Wound widths were 
determined 0 and 24 hours after wounding. (n=3, values represent the mean ± SEM, 
**: p<0.01, ****: p<0.0001, n.q.: non-quantifiable due to massive cell death). NB: The 
medium used was a 1:1 mixture LA-4 medium (HAM):PAO1 medium (MOPS), this explain 
the subpar repair of the wound for the untreated group. 
 
Pseudomonas aeruginosa is a common opportunistic pathogen and is responsible for 
chronic as well as acute infections. In vivo, the bacterial contamination can lead to 
local high levels of AHL and other bacterial secretion in the supernatant, resulting in 
cell death during biofilm development [142]. However, these effects were more 
dramatic in vitro where the generally toxic bacteria-free supernatant induced the 
epithelial death. Therefore, this in vitro model is not supporting any effects of AHLs 
on wound healing. In the aim of using 3-oxo-C12-HSL therapeutically against 
inflammation, this study further pursued the underlying mechanisms of the 
modulation of the inflammation by investigating the effects of acute injuries in vivo. 
Various models of acute lung injuries exist, each with their pros and cons [143]. In the 
following animal experiment, the acute lung injury was performed via LPS 
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intratracheal instillation. This invasive method allows further observations of 
biological changes, like changes in protein secretion, as well as pathological changes, 
such as neutrophilic alveolar infiltrates. The application of a precise volume of the 
LPS solution allows a good reproducibility and a non-fibrotic repair phase [144], 
together with a measurable alveolar neutrophil recruitment. 
 
6. In vivo Acute Lung Injury (ALI) can be modulated by 
bacterial effectors 
ALI is an inflammatory model developed to recreate inflammation in vivo or in vitro 
without the risk of putting in contact live pathogens in the organism of interest 
[10,145], with a quick onset (typically less than half an hour), followed by a total 
resolution of the inflammation (at least 95%) within 72 hours [146]. In this study, 
LPS was applied intratracheally to 6-8-week-old female C57BL/6J mice, either half 
an hour prior, or six hours prior to the bacterial molecule treatment. C57BL/6J is a 
common inbred mouse strain, widely used in pulmonary studies. However, it differs 
from the other widely used strain BALB/c by its higher Th2 response in the lungs 
and overall higher cytokine release upon antigen sensitization [147].  
LPS is known to activate the NF-κB pathway through TLR4 signaling, thereby 
classically polarizing AM and driving pro-inflammatory cytokine release, which in 
turn induces inflammatory cells recruitment [100]. The inflammation in the lung can 
be quantified by various techniques [148]. Here, the main focus was on cell number 
and population, Broncho-alveolar lavage (BAL) protein concentration and mRNA 
levels of inflammatory markers in whole lung homogenates. 
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7. Application of QS-molecules failed to reduce LPS induced 
neutrophil recruitment 
AHL were instilled intratracheally and tested for pro-inflammatory or toxicity 
potency, as it would interfere with the LPS induced ALI (Figure 19). No dose 
response was observed between 300 and 1200 μM in the AHL treated mice. 24h after 
AHL treatment, BAL sampling showed no significant difference in PMN numbers 
between the PBS and AHL instilled mice (<10%). These results suggest that AHL or 
ACN alone do not trigger any acute inflammation upon treatment with doses up to 
1200 μM. 
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Figure 19. No inflammation is observed after AHL instillation up to 1200 μM. 
AHL or ACN were instilled into the lungs of mice at concentrations up to 1200 μM. This did 
not trigger BAL neutrophil recruitment (neutrophils < 10% total cells). BAL was harvested 
after 24h and cells counted manually after May-Grünwald-Giemsa staining (n=2/condition). 
 
Neutrophils migrate to the lung alveoli during an ALI. Thus, a neutrophil count is a 
robust indicator of the inflammatory state [149–151] of a lung as well as the lung 
fluid composition. To test the eventual inflammatory dynamics of AHL in vivo, mice 
were instilled a first time with LPS and 6 hours later with AHL. This protocol 
enabled us to monitor the therapeutic effect of AHL on ALI, as a reduction of 
cytokine concentration or cell number would indicate a reduced response on the 
inflammation process. The mice were treated with the highest doses of AHL and 
RESULTS 
73 
ACN not triggering an inflammation to purposely hit the maximum efficiency against 
the LPS induced inflammation. However, no reduction in neutrophil numbers 
reduction was observed in the BAL upon the AHL treatment, even for doses as high 
as 1200 μM (Figure 20). These results showed that a direct effect from QS molecules 
against acute inflammation cannot be found in this experimental system. On the 
other hand, AHLs have been shown to participate to PMN recruiting [75]. Recent 
studies [67] discovered that probiotic bacteria release molecules which may allow a 
quicker resolution of the inflammation. 
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Figure 20. BAL neutrophils recruitment after LPS instillation is not affected by 
3-oxo-C12-HSL. (A) May-Grünwald-Giemsa staining of control (PBS) and (B) inflamed 
(LPS) lung. (C) 3-oxo-C12-HSL (1200 μM), ACN (4%) or control (PBS) were co-instilled 
with LPS (6h delay). BAL was harvested 24h later and cells were counted manually (n=5). 
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II- EFFECT OF D-TRP OF PROBIOTIC GRAM-POSITIVE 
BACTERIA ON LUNG EPITHELIUM AND IMMUNITY 
 
1. Probiotic bacterial molecules modulate the innate pulmonary 
response 
Following the previous results showing that the AHL structure was affecting 
macrophages polarization [78] and Th cells differentiation [112], it was hypothesized 
that other bacterial small molecules could modulate the immune response too. It has 
been shown recently by Kepert et al. [67] that supernatant from Gram-positive 
probiotic bacteria strains (e.g. Lactobacillus casei) decreased Chemokine (C-C motif) 
ligand 17 (CCL17) cytokine secretion in human Hodgkin lymphoma cell line as well 
as Th2 response in mice. The active molecule was identified as D-tryptophan (D-Trp), 
while L-Trp and other amino acids were immunologically inactive. The D-Trp 
relative innocuity [152], specificity and affordable price could lead to acute or chronic 
inflammation treatment. Here D-Trp effects were compared with the previously 
described AHL-effects on AM polarization, wound healing and inflammation 
resolution. 
 
2. In vitro D-Trp impairs M1 macrophages inflammatory 
phenotype 
Various D-amino acids were used as controls, chosen for their chemical similarities 
(i.e. acidity; aromaticity) with D-Trp: Tyr, Phe, Met, His, and Pro (Figure 7). None 
of them displayed a significant effect on AM polarization (Suppl. Fig. 6). The 
LPS/IFNγ stimulation effectively drove the M1 polarization (Figure 21). D-Trp alone 
did not induce a biologically significant expression of Tnf, Il1b or Nos2 (NRQ<0.1). 
After 24h of D-Trp/LPS treatment, Tnf and Il1b showed reduced expression, ranging 
from 3.6 to 3.8 folds respectively and Nos2 was only non-significantly reduced at 1.7-
fold (Figure 21) compared to the DMSO vehicle control (1%). Furthermore, the 
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effects on Tnf were observed for doses as low as 10 μM D-Trp. These results 
suggested that D-Trp impairs M1 polarization of AM in vitro via the downregulation 
of key inflammatory genes. It is important to notice the biological effect induced of 
DMSO alone. This biologically compatible chemical was used in numerous previous 
studies as a vehicle agent [153,154], chosen for its relative inertia towards organisms. 
Furthermore, the DMSO M0 control was cut down compared to the Non-Template-
Control (NTC, media only control) by 90 folds. After these findings were reproduced 
and confirmed, it became urgent to reflect and rely on a different vehicle control, as 
detailed in 2.4. 
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Figure 21. D-Trp effects on LPS/IFNγ induction of Tnf (A), Il1b (B) and Nos2 
(C) mRNA expression in AM. MH-S cells were analyzed 24h after AHL/LPS treatment 
for mRNA expression relative to Hprt.  
M0: no polarization; M1: LPS(+)/IFNγ(+). (n=3, values represent the mean ± SEM, 
*: p<0.05, ***: p<0.001) 
RESULTS 
77 
Alike to the results observed with the AHL, the amount of protein secretion 
subsequent to the LPS/D-Trp treatment was measured. The data showed that LPS 
treatment together with a low dose of D-Trp (10 μM) increased the extracellular 
amount of TNFα by 1.5-fold (Figure 22). This effect was however lost with higher 
doses of D-Trp. As for the results obtained in Figure 11, it is likely that the reasons 
for the discrepancies observed between the gene expression and the protein secretion 
are found in the simultaneous sampling of both the genetic material and the cell 
supernatant. Indeed, gene expression and protein release do not occur at the same 
time. 
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Figure 22. D-Trp treatment increases LPS/IFNγ  induced TNFα release in M1. 
MH-S cells supernatant was analyzed 24h after D-Trp/LPS treatment. 
M0: no polarization; M1: LPS(+)/IFNγ(+). ELISA assay. (n=3, values represent the mean 
± SEM, ***: p<0.001) 
 
3. In vitro D-Trp stimulates M2 polarization 
Low doses of D-Trp triggered the pro-inflammatory cytokine TNFα secretion, hence 
showing the potency of this amino acid to increase LPS stimulated M1 polarization. 
Next, this study aimed to confirm whether not only the M1 but also the M2 
polarization could be altered by the D-Trp cotreatment. To this end, Arg1, Mrc1 and 
Il10 gene expression, previously described as classic M2 markers [118], were measured. 
Arg1 and, to some extent also Il1b, displayed significant higher levels of mRNA levels 
compared to the vehicle control in the M2 polarized group. A moderate decrease of 
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Il10 mRNA expression was also observed in the M2 polarized group (Figure 12). Arg1 
and Mrc1 displayed higher levels of mRNA expression when treated with D-Trp in 
the M2 polarized group. These findings indicate a shift towards M2 polarization after 
D-Trp treatment in vitro, illustrating a reinforced anti-inflammatory phenotype in 
the presence of both D-Trp and IL-4, at concentrations as low as 10 μM. The results 
corroborated the hypothesis that D-Trp induces an immune tolerance where the 
effects were driven towards the suppression of T cells proliferation as described in 
previous studies [102]. This could be explained by D-Trp modulating Mrc1 expression 
through the IDO enzyme [155]. 
Mrc1
D
M
SO
10
 µ
M
50
 µ
M
10
0 
µM
0.001
0.01
0.1
1 M0
M2
N
R
Q
****
D-Trp
Arg1
D
M
SO
10
 µ
M
50
 µ
M
10
0 
µM
0.000001
0.00001
0.0001
0.001
0.01
0.1
1
N
R
Q
**
D-Trp
 
Figure 23. D-Trp treatment increases IL-4 induced Arg1, and Mrc1 mRNA levels 
in AM. MH-S were analyzed 24h after AHL/LPS treatment for mRNA expression relative 
to Hprt.  
M0: no polarization; M2: IL-4(+). (n=3, values represent the mean ± SEM, **: p<0.01, 
****: p<0.0001) 
 
4. High concentration of D-Trp drives M1 polarization in 
AEC/AM cocultures 
Considering the highest D-Trp concentration tested in cocultures of AM with alveolar 
cells type 2 (AECII) (100 μM), the results showed that without other stimuli, 
unpolarized AM increased their Tnf and Il1b expression by 4 and 11 folds respectively 
(Figure 24 A). This effect was not seen for AM monocultures. This suggest that 
AECII in collaboration with AM recognize high amounts of D-Trp and increase pro-
inflammatory genes expression. However, this effect is lost under low D-Trp 
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concentrations, where Tnf and Il1b level are comparable with the control after LPS 
stimulation. 
Surprisingly, no significant effect was observed on the Arg1 mRNA expression level, 
representative of the AM alternative polarization (Figure 24 B). Indeed, it has 
previously been shown during in vitro studies that consecutively to AM apoptosis and 
TNFα secretion, AECII were producing IL-6, which in turn increased M2 related gene 
expression [14,156]. 
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Figure 24. 100 μM D-Trp treatment promoted (A) Tnf and Il1b mRNA 
expression for M0 AM, and (B) did not influence IL-4 induced Arg1 level in 
AM/AECII coculture. MH-S/LA-4 cells were analyzed 24h after D-Trp/LPS treatment 
for mRNA expression relative to Hprt.  
M0: no polarization; M1: LPS(+); M2 : IL-4(+). (n=3, values represent the mean ± SEM) 
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5. Wound healing efficiency is mildly reduced by D-Trp 
treatment on AECII monolayer 
Racemic (D-/L-) Trp has been shown to help wound healing of skin related injuries 
[157,158]; however, its effect on the lung epithelium had not been studied yet. Two 
AECII cell lines (LA-4 and MLE-12) were selected to assess the possible cell 
specificity of D-Trp. The results showed that similar to the previous AHL 
experiments, D-Trp did not promote epithelial wound healing on AECII/AM 
cocultures. The data even showed a minor reduction in wound healing for both cell 
lines LA-4 and MLE-12 after 24h D-Trp treatment (100 μM and 10 μM respectively). 
In comparison to the AHL effects on wound healing, D-Trp had a rather low 
biological impact on the repair process (Figure 17 and Figure 25) with an average 
repair above 75% for all conditions. In total, D-Trp did not support AECII/AM 
repair in our model of lung epithelium physical injury. The mechanical stress 
obtained during the injury likely promoted the AM to a M1 polarization, increasing 
TNFα release and subsequently TGF-β1 production. The TNFα increase due to the 
exogenous D-Trp (Figure 22) created a cytokine rich environment, potentially 
contributing to a dysregulated epithelial wound repair [159]. 
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Figure 25. D-Trp mildly impairs wound closure of AECII monolayer and 
AECII/AM coculture. LA-4/MLE-12/MH-S cells were cultivated from 0 to 24h after 
simultaneous scratch and treatment with PBS or D-Trp (10-50-100 μM). Wound widths were 
determined 0 and 24 hours after wounding. (n=3, values represent the mean ± SEM, 
*: p<0.05)
RESULTS 
81 
6. D-Trp moderately limits neutrophil (PMN) recruitment after 
acute lung injury (ALI) 
The probiotic by-product D-Trp, as presented before, displays a distinctive structure 
compared to the AHL and possesses also a mode of action independent of TLRs. In 
this study, D-Trp has been shown to induce various pro- and anti-inflammatory 
signals in vitro. To further investigate its potential anti-inflammatory effects, a 
similar protocol as used with the AHL was set. Firstly, a gradient of D-Trp was 
tested to determine the best concentration to use, aiming for a robust therapeutic 
effect, considering the limits of an intratracheal application, as well as the potential 
toxicity of D-Trp (Figure 26). No significant PMN recruitment was observed for D-
Trp concentrations up to 1 mM. The local concentration is expected to be much 
lower than 1 mM due to dilution effect in mucus [160]. 
During the course of acute lung injury (ALI), the D-Trp treatment time of instillation 
can be crucial. Since the potency of the amino acid is unknown, D-Trp can be used in 
the early onset of the inflammation, a few hours later, or during its peak. The LPS 
induced inflammation is peaking between 8 and 24h [161,162]. Hence, the treatment 
should be administered before this window. Two possible mode of actions of the D-
Trp treatment are hypothesized. On one hand, D-Trp could carry anti-inflammatory 
properties, reducing the level of inflammation at peak time (8-24h). Alternatively, D-
Trp could support a pro-resolving effect, playing a role after the inflammatory peak 
(24-48h). Analyzing BAL content before and after the peak would allow to assess the 
resolution kinetics and give evidence towards a possible mode of action. 
To cover two time points, a simultaneous as well as a 6h delayed application was 
chosen for the D-Trp treatment. Indeed, the tracheal treatment is a semi-invasive 
technique; in regard of the animals’ stress level and to minimize unwanted 
interactions, the mice should also benefit from a resting time between the anesthesia. 
After the establishment of an ALI, the 6h delay between LPS and D-Trp application 
was crucial to obtain a biologically relevant effect on PMN recruitment (Table 4). 
These results gave evidence for an anti-inflammatory mode of action. Also, the time 
course of the ALI revealed that the peak of the inflammation likely occurred before 
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24h (Figure 27). Furthermore, simultaneous treatments did not influence PMN 
numbers in the BAL, making a preventive treatment against ALI unlikely to have 
positive responses. A larger scale experiment confirmed the previous results: when D-
Trp treatment occurred 24h after ALI, the total number of BAL cells and PMN were 
significantly reduced (Figure 28). A higher cell number reflects a stronger 
inflammation, characterized by a higher vessel permeability correlated with a higher 
cytokine concentration. 
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Figure 26. Intratracheal application of D-Trp does not trigger PMN at 
concentrations up to 1 mM. Percentage of PMN in BAL 24h after D-tryptophan 
application. 0 to 1 mM (50 μl) D-Trp were applied in vivo intratracheally. BAL was 
harvested after 24h and cells were counted manually (n=4/condition). NB: The PBS control 
reaching 22% PMN can be explained by the invasive treatment method where small lesions in 
the trachea can appear during the intubation, creating a small inflammation on its own. 
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Figure 27. D-Trp reduces neutrophils recruitment when applied 6h after LPS. 
Percentage of PMN in BAL 24/48h after LPS with or without D-Trp treatment 
(simultaneous or 6h delayed). (A) 24h (B) 48h after LPS treatment. (n=3/condition) 
 
 
  
SIMULTANEOUS 6h DELAYED 
  
PBS D-Trp 1mM PBS D-Trp 1mM 
24h 
PMN (% total cells) 
93,17 90,08 91,75 79,00 
48h 72,92 72,92 66,58 54,33 
  PMN reduction 22% 19% 27% 31% (p=0.06) 
Table 4. Summary data of neutrophils presence in BAL after LPS induced ALI. 
Percentage of PMN in BAL 24/48h after LPS with or without D-Trp treatment 
(simultaneous or 6h delayed), (n=3/condition) 
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Figure 28. D-Trp, but not L-Trp treatment reduced BAL PMN numbers 24h 
after ALI. BAL cell-count 24h after D-Trp (1 mM, 6h delayed) intratracheal instillation 
(n=6-15). (*: p<0.05, ***: p<0.001, unpaired t test with Welch correction) 
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7. CCL17 concentration declines in BAL after ALI and D-Trp 
treatment 
BAL cytokine analysis and quantification were performed to assess the onset of 
inflammation and to understand at which level D-Trp interferes with the epithelium. 
Following the results showing a lower BAL cell count by D-Trp treatment, a mild 
reduction of the total BAL protein was observed (Figure 29). ELISA immunoassays 
and Bradford protein assay were then conducted to characterize the BAL constitution 
during the resolution of ALI. Protein candidates were chosen considering their 
relevance on immune cells during ALI. The chemokine (C-X-C motif) ligand 1 
(CXCL1) is a major cytokine involved in triggering PMN recruitment, mediated by 
both TNFα and NF-κB signaling [163] (Suppl. Fig. 8; CCL17 is implicated in 
effector/memory Th1 lymphocytes attraction and is elevated at several inflammatory 
conditions [164–166]). Furthermore, several D-Trp containing probiotic supernatants 
have been shown to decrease CCL17 expression (human Hodgkin lymphoma KM-H2 
cells), as well as reducing costimulatory molecules of LPS-stimulated human dendritic 
cells [67]. To extend Kepert et al. results to lung injuries, CCL17 concentration was 
measured. D-Trp treatment 6h after LPS instillation significantly reduced CCL17 
expression (5 mM) in the BAL 24h after LPS instillation, as previously described in 
vitro [67]. Also, a trend towards reduced CXCL1 expression was observed after D-Trp 
instillation (Figure 30). The 5 mM dosage was provided in order to validate the mice 
tolerance for a high dosage of D-Trp in an injured environment. Altogether these 
results confirm that D-Trp has an active role in inflammatory protein modulation. 
However, the molecular cascade leading to a faster resolution of the inflammation is 
unclear. 
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Figure 29. D-Trp treatment did only slightly influence BAL protein 
concentration after LPS treatment. BAL protein concentration 24h after D-Trp or L-
Trp (1 mM) intratracheal application. BCA assay (n=4-15). 
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Figure 30. High concentration of D-Trp (1 mM) tend to reduce the expression of 
key inflammatory cytokines in the BAL. BAL cytokine concentration 24h after LPS 
instillation. Assessed by ELISA (n=4-15). (*: p<0.05, ***: p<0.001, unpaired t test with 
Welch correction) 
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8. D-Trp reduces mRNA expression of CD11b, Alox12 and 
Fpr2 in whole lung homogenate 
In this study, the data showed that BAL cytokine concentration and PMN numbers 
were reduced after ALI and D-Trp treatment. Lower PMN numbers and a shift 
towards reduced inflammation or enhanced resolution can be highlighted by lung 
mRNA analysis. 
D-Trp metabolism is brought about by intracellular and extracellular mechanisms, 
bringing into play its biosynthesis in microbes (Suppl. Fig. 9) and its metabolism in 
pro- and eukaryotes (Suppl. Fig. 10). This study focused on the latter, considering 
that mammalians are unable to synthesize it [66]. The previous experiments indicated 
that inflammatory pathways were modulated by D-Trp treatments in vivo leading to 
reduced inflammatory response or/and enhanced resolution. Indeed, evidence of 
changed cell populations as well as in cell number, together with reduced 
inflammatory cytokine concentration showed an altered composition of the BAL. 
However, the pathways in place responsible for PMN or AM recruitment were still 
unidentified. Transcript analysis from whole lung was then analyzed to gain an 
insight on the mechanisms leading to modulated inflammation. It was hypothesized 
that PMN were majorly responsible for the release on the investigated inflammatory 
cytokines CXCL1 and CCL17, as well as resident macrophages and recruited AM, 
participating both in the first response and the injury resolution. Then, the 
expression of a small panel of genes was studied, consisting of previously described 
common PMN and AM markers, as well as D-Trp receptors involved in D-Trp 
metabolization. Integrin alpha M (CD11b) is expressed by several leucocytes, 
particularly PMN (CD11clowCD11bhigh) [167] and inflammatory activated alveolar 
macrophages [167]. Its mRNA levels were reduced by a factor of 4 in D‑Trp treated 
lungs (Figure 31), while BAL PMN numbers have been found to be reduced by 10%. 
This decrease in CD11b expression suggests that in addition to the contribution from 
a reduction in PMN numbers in the lung, persisting 24h after LPS application, also 
other cells such as CD11b+ macrophages might show reduced activation upon D-Trp 
treatment. Serum amyloid A 3 (Saa3), a well described inflammatory factor [168], 
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rapidly and powerfully induced by LPS in lung macrophages, was not regulated by D-
Trp. This argues that the initial response to LPS was not affected by D-Trp. To 
monitor the regulation of inflammation, the expression of murine 12-lipoxygenase 
(ALOX12) resolution protein, the analogue to the human 15-lipoxygenase (ALOX15) 
[169–171], was studied. In the biosynthesis of lipoxins and other pro-resolving 
mediators, ALOX15 has a pivotal role in the resolution of inflammatory responses 
[172]. Its concentration is increased in M2 macrophages after IL-13 activation due to 
its positive feedback loop. Altogether, ALOX12 participates in the resolution of the 
inflammation through the synthesis of lipoxins [173] (Suppl. Fig. 11). However, no 
significantly increased expression of Alox12 was observed, nor of the lipoxin receptor 
FPR2 [174] (Figure 31). This may be explained by the time course of the experiment: 
IL-13 activation and subsequent polarization of the macrophages requires previous T 
cell recruitment and interaction in the lung. Probably, the 24h window was too short 
to measure the responses. 
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Figure 31. (A) D-Trp effect on CD11b and Saa3 expression as well as on (B) 
macrophages inflammation markers Alox12 and Fpr2 in whole lung homogenate 
24h after LPS (t=0) and D-Trp treatment (t=6h). mRNA expression relative to Hprt 
(n=4-15). (*: p<0.05, **: p<0.01, unpaired t test with Welch correction). 
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9. IL-6 increase in AhR-/- M1 BMDM is reduced after D-Trp 
treatment. 
Following earlier results showing the direct or indirect involvement of the aryl 
hydrocarbon receptor (AhR) on lung immunity, this study aimed to discover whether 
D-Trp anti-inflammatory effect is dependent on the presence of the AhR using AhR-/- 
cells. Bone marrow macrophages from AhR-/- (Ahrtm1Bra) mice [175,176] were cultured 
for seven days, differentiated into AM, and polarized following the method described 
in MATERIALS AND METHODS (Table 5). The polarization efficiency was 
measured through the levels of robust AM mRNA markers and proteins. 
 
AhR-/- and 
AhR-/+ 
PBS 
D-Trp 
50 μM 
D-Trp 
100 μM 
L-Trp 
100 μM 
LPS 
(1 μg/mL) 
x x x x 
IL-4 
(20 ng/mL) 
x x x x 
No polarization x x x x 
Table 5. Combination matrix of experimental planning. 24h stimulation of LPS (M1 
AM), IL-4 (M2 AM) combined with D-Trp/L-Trp application). 
 
The inflammatory cytokine IL-6 was induced to higher levels in AhR-/- BMDM. 
These results confirmed previous works [177], where the aryl hydrocarbon receptor 
was described as the cornerstone of the tolerance defense pathway. The early 
response failed unless the AhR+/- was activated by D-Trp (Figure 32). Furthermore, 
relative to PBS, high dose of D-Trp (100 μM) induced IL-6 in AhR+/- BMDM but 
was repressed in AhR-/- cells. These results were confirmed to a lesser extend at 
protein level, where supernatants of D-Trp treated AhR-/- cells showed slightly lower 
concentration of IL-6 than the PBS control cells (Figure 33). M2 marker (Mrc1 and 
Arg1) were increased in D-Trp/IL-4 polarized BMDM only in the AhR+/- genotype. 
It suggests that AhR plays a role in early inflammation response helping M2 
polarization. All these results pointed towards AhR and NF-κB downstream signaling 
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leading to an increased Cytochrome P4501-1A1 (CYP1A) activity as well as 
xenobiotic metabolism through the kynurenine pathway. 
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Figure 32. mRNA expression levels of inflammation markers in response to L-
/D-Trp in AhR-/- and AhR+/- BMDM after (A) LPS and (B) IL-4 stimulation. 
AhR-/- BMDM display increased Il-6 and Mrc1 expression after LPS stimulation, reduced to 
WT level after D-Trp treatment. BMDM were incubated 24h after D-Trp or L-Trp 
treatment and polarization. The mRNA expression is relative to Hprt. (n=6, values represent 
the mean ± SEM, *: p<0.05) 
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Figure 33. IL-6 concentration after L-/D-Trp treatment in AhR+/- and AhR-/- 
mice. AhR-/- BMBM showed increased IL-6 concentration after LPS stimulation. BMDM 
were incubated 24h after D-Trp/LPS treatment. ELISA assay (n=6, values represent the 
mean ± SEM, **: p<0.01, ***: p<0.001, ****: p<0.0001). 
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10. AhR signaling mediates D-Trp activity through both the 
kynurenine and the Cyp1a1 pathway and NF-κB regulation. 
D-Trp and L-Trp are both agonists of the aryl hydrocarbon receptor (AhR) [178]. 
However, D-Trp might have a much greater affinity to the receptor (Figure 34), 
which could be explained by the configuration difference between the two amino acids 
[179]. It had been shown that AhR is involved in immune responses, and that LPS 
stimuli induced an AhR-dependent CYP1A1 increase [176] (Figure 35). The absence 
of AhR reduced mRNA expression of key proteins in the kynurenine and the NF‑κB 
pathways for both LPS and IL-4 treated BMDM was tested. Furthermore, D-Trp 
displayed a bioactivity threshold of 100 μM, from which BMDM drastically increased 
Ido1 and Cyp1a1 mRNA expression. The increased activity of AhR by D-Trp binding 
could be part of a feedback loop involving D-Trp metabolites [180]. This increased 
metabolic activity of D-Trp is consistent with the regulation of immunity observed in 
AM through inflammation, towards an increased or faster response. 
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Figure 34. AhR dependent Ido1 (A) and Cyp1a1 (B) mRNA expression in 
AhR+/- and AhR-/- BMDM. D-Trp increases mRNA expression of Ido1 and Cyp1a1 (key 
AhR downstream targets) in BMDM. BMDM were incubated 24h after LPS or IL-4 
treatment. The mRNA expression is relative to Hprt. (n=6, values represent the mean 
± SEM, **: p<0.01, ***: p<0.001) 
 
 
Figure 35. Molecular mechanism of activation of gene expression after AhR-
ligands interaction [178]. Exogenous ligands penetrate the cell through lipid interactions 
and binding to the AhR. 
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11. D-/L-Trp impairs a key enzyme of the AhR/kynurenine 
pathway  
Eukaryotes regulate the Trp-metabolization through different enzymes participating 
to the indole, kynurenine or serotonin pathway (Suppl. Fig. 10). D-/L-Trp is an 
agonist of the AhR-receptor, mediating immune tolerance and immunity following 
IDO induced D-/L-Trp catabolization through the kynurenine and AhR activation 
pathway (Figure 36) [181]. 
The focus was made on the kynurenine pathway, being downstream the recognition of 
D-Trp recognition by the AhR. Indeed, evidence suggests that the kynurenine 
pathway is participating in T-cells modulation, and more generally in mediating 
reduced immune response [102,176]. The first and limiting step of this pathway is the 
catabolization of the L-Trp and D-Trp into kynurenine by the Indoleamine 2,3-
dioxygenase 1 enzyme (IDO1) [182]. Surprisingly, Ido1 expression in the whole lung 
was reduced after D-Trp treatment which contrast with the hypothesis that a greater 
Trp intake would increase the enzyme metabolic activity (Figure 37), nor was it 
increased consequently to a TNFα inflammatory response [79], [80]. D-Trp is more 
likely to be metabolized involving other enzymes also participating to the kynurenine 
pathways such as the tryptophan 2,3-dioxygenase 1/2 (TDO1/2) or IDO2. These 
findings unraveled the AhR as a key player in D-Trp mediated immunity, especially 
in acute inflammation. 
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Figure 36. Ido1 mRNA expression in whole lung homogenate 24h after 
consecutive LPS and L-/D-Trp treatment. mRNA expression relative to Hprt 
(n=4‑15). (**: p<0.01, unpaired t test with Welch correction) 
 
 
 
Figure 37. Toll-like receptor ligands trigger transcriptional activation of STAT-1 
and NF-κB, and then induce IDO mRNA. Adapted from [181]. 
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DISCUSSION 
 
I- EFFECT OF N-ACYL HOMOSERINE LACTONE 
COMPOUNDS OF GRAM-NEGATIVE BACTERIA ON 
LUNG EPITHELIUM AND IMMUNITY 
 
1. Quorum sensing and Pseudomonas aeruginosa 
Quorum sensing (QS) signaling molecules are not necessarily limited to bacterial-
bacterial signaling [183,184] but also involved in inter-kingdom communication, for 
example with human immune cells [185]. In that context they may not exclusively be 
linked to pathogenesis either considering that QS is used in plants by several 
probiotic bacterial species; this mechanism being the reflection of their ability to 
colonize various niches [70]. For example for the bacteria Pseudomonas aeruginosa 
(PAO1), the prominent QS molecule 3-oxo-dodecanoyle homoserine lactone (3-oxo-
C12-HSL), from the acyl-homoserine lactones (AHL) family, is secreted and recognized 
by a set of two major bacterial signal components: LasI/LasR and RhlI/RhlR [186]. 
However, 3-oxo-C12-HSL can beyond bacterial interaction also modulate the 
immunity of the host [74–78,85] by activating non canonical immune pathways, 
independent from pathogen-associated molecular pattern (PAMPs) and the respective 
pattern recognition receptors (PRRs) [90]. 3-oxo-C12-HSL controls the production of 
Pseudomonas aeruginosa virulence factors [187], giving it a selective advantage in 
pathogenic interactions. Besides N-Acyl-HSL, AQ-QS system exists in P. aeruginosa, 
which is able to modulate the immune response to human bronchial epithelial cells 
[137]. 
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2. 3-oxo-C12-HSL effect on Th2/17 cells differentiation 
It has been previously shown that 3-oxo-C12-HSL inhibits Th2 differentiation [77]. 
The differentiation of the Th cells was assessed from their ability to produce their 
relevant cytokines. Interestingly, our findings suggest for the first time that C12-HSL 
(50 μM/48h) mildly impairs IL-4 production of Th2 cells (Figure 9). Furthermore, it 
has been demonstrated that IL-17 production increases rapidly after Pseudomonas 
infection [188]. In the same manner, our results illustrated an increase of IL-17 
production on the Th17 differentiated cells after 3-oxo-C12-HSL stimulation (100 
μM/48h and 100 μM/96h). 3-oxo-C12-HSL and C12-HSL possess similar molecular 
features (lactone ring and alkyl chain length). This could explain the comparable 
reactivity of the two AHL. 
The results presented in this doctoral thesis suggests a shift of Th cells differentiation 
towards Th17 as well as a reduction in Th2 differentiation. The Th immune cells upon 
AHL-application present a more inflammatory phenotype. Earlier hypotheses support 
a ubiquitous impairing role of AHL on immune cells in both innate and adaptive 
immune response. However, no significant AHL-induced anti-inflammatory effect was 
observed, despite being discussed in previous studies [78]. 
3-oxo-C12-HSL has the highest potency for IL-17 induction, while C12-HSL has the 
highest potential for IL-4 repression. These findings indicate that the actions of 
different AHLs rely on different pathways or receptors in differentiated T cells. 
Consequently, the impact of AHL on T cell cytokine production suggests a complex 
model involving possibly other immune response cells mediating the interaction. 
Indeed, T cells maturation is triggered by APC/T cell co-stimulation involving T 
cells receptors (TCR) and the major histocompatibility complex (MHC) [189]; the 
APCs consisting mostly of DCs and macrophages in a lesser extent. Newly 
differentiated Th cells will then in turn recruit macrophages via inflammatory 
cytokines (i.e. IFNγ) to the site of inflammation [190]. Thus, airborne bacteria 
encounter first AM and epithelial cells in the lungs. This may subsequently modulate 
T cell recruitment or function. Thus, in current experiments the focus was set on the 
effects of AHL on AM polarization, and epithelial barrier function. 
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3. 3-oxo-C12-HSL modulation of AM polarization and function 
In the lung, the first line of defense can be seen in the alveolar epithelium, which 
oversimplified consists of epithelial cells type I and type II (AECI and AECII) and 
alveolar macrophages (AM). AECI cells cover 98% of the alveolar surface to maintain 
the gas exchange between the alveoli and blood [191,192], and AECII cells secrete 
surfactant, maintain the fluid balance and have also been described as defender of the 
alveolus [193]. The tissue resident AM are known for their effective uptake of inhaled 
particles, to fight microbes [34], and to mediate acute lung inflammation and 
resolution in many disease conditions [194]. 
3-oxo-C12-HSL through its auto-paracrine signaling [71] has been shown to reduce the 
expression of inflammatory cytokines in AM [78]. 3-oxo-C12-HSL significantly 
inhibited the LPS-induced inflammatory response in macrophages by reducing the 
secretion of pro-inflammatory TNFα, and increasing anti-inflammatory interleukin 10 
(IL-10) [78]. It was shown in this thesis work, in a novel coculture model of AM and 
AECII cells, that 3-oxo-C12-HSL increased the polarization of M2 polarized AM 
(Figure 15). These findings suggested an anti-inflammatory activity of the AHL 
causing a M2 shifted polarization. Mechanistically, this anti-inflammatory effect can 
be explained by the fact that 3-oxo-C12-HSL impaired the activation of NF-κB 
functions which subsequently repressed the expression of inflammatory cytokines such 
as TNFα [89,195]. Other findings, in contrast, suggested that through a mechanism 
involving inflammatory signaling of protein kinase RNA-like endoplasmic reticulum 
kinase (PERK) and Eukaryotic Initiation Factor 2 alpha (eI-F2α,3-oxo-C12-HSL can 
activate PERK phosphorylation and eI-2Fα inhibition. This subsequently reduces the 
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha 
(IκBα production and activated NF-κB p65 production [154]. This finally increases 
chemokine (C-X-C motif) ligand 1 (CXCL1) and interleukin 6 (IL-6) transcription, 
and thus selectively induces neutrophil chemotaxis [86]. 
Until 2018, in vivo immunomodulatory effects of AHL on live animals have not been 
described. In this thesis, the effects of intratracheal applied AHL on an inflamed lung 
of C57BL/6J mice were evaluated to further identify, if AHL treatment could reduce 
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lung inflammation, neutrophil recruitment, and inflammatory cytokine levels. To rule 
out any possibility of autoinflammation, a dose response was conducted. Despite the 
relatively small group size (2), dose response up to 1200 μM resulted in comparable 
cell recruitment as in the ACN control treatment (5-10% of total cells), indicating 
that the AHLs alone did not induce any obvious pro- or anti-inflammatory effect 
(Figure 19). 
An impairment of the NF-κB pathway is linked to the inhibition of the peroxisome 
proliferator-activated receptor gamma (PPARγ), an important anti-inflammatory 
antagonist of NF-κB [91]. The impairment of PPARγ results in a further decrease of 
downstream functions such as wound repair, homeostasis, and control of 
inflammatory energy [196]. Disruption of barrier integrity has been observed after 3-
oxo-C12-HSL treatment on Caco-2 epithelial cells, and could be prevented by 
inhibition of p38 p42/p44 Mitogen-activated protein kinases (MAPK) [83], reducing 
thereby macrophage phagocytosis [197]. Results presented in this thesis (Figure 16 
and Figure 17) supported in vitro impairment of wound repair by 3-oxo-C12-HSL 
application for two AECII cell lines (LA-4 and MLE-12), independently of the 
presence of LPS (1 μg/mL). 
 
4. Quorum sensing receptors 
3-oxo-C12-HSL receptors on the host cells have been partially elucidated; one target 
receptor of a variety of AHLs on epithelial cells seems to be the Ras GTPase-
activating-like protein IQGAP1 (IQGAP1) [86,96,198]. Other groups identified the 
taste receptor T2R38, present on peripheral blood neutrophils, monocytes, and 
lymphocytes, as responsible for the entry of AHLs into the cell [96]. When in contact 
with AHL, epithelial cells triggered also a cascade leading to a calcium dependent 
repression of NO production in AM [199]. Very recent publications link the 3-oxo-C12-
HSL target entry into the cell to the PPARs for human lung epithelial cells and 
murine fibroblasts [76,200]. Jahoor et al. argued that the proinflammatory effect of 3-
oxo-C12-HSL on murine fibroblasts and human lung epithelial cells could be blocked 
by the PPARγ agonist RGZ [76], suggesting a mutually antagonistic mode of action 
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of the two compounds on PPARγ. These results were corroborated in vitro, where 
RGZ pre-treatment reduced Tnf expression after 3-oxo-C12-HSL stimulation (Figure 
15 and Suppl. Fig. 1). 
Interestingly, it has been shown that the neutrophils, monocytes and macrophages 
taste receptor T2R38 [92] is activated by 3-oxo-C12-HSL and its surface expression 
[201], regulating a calcium dependent NO production [199]. This defense mechanism 
is hypothesized to help mucociliary clearance during airway bacterial infection. Our 
results showed however a decreased expression of T2R38 in M1 AM in vitro after 3-
oxo-C12-HSL treatment (Suppl. Fig. 3). This suggests that the mechanism leading to 
T2R38 over-expression do not rely solely on 3-oxo-C12-HSL. In a preliminary array 
experiment, all the analyzed taste receptors showed weak baseline expression and 
expressed no significant difference between the M1 and M2 subtypes (Suppl. Fig. 4). 
Of notice, Lee et al. [199] used a higher 3-oxo-C12-HSL concentration (100 μM vs. 
60 μM), possibly leading to the higher gene expression effect. 
 
II- EFFECT OF D-TRP OF PROBIOTIC GRAM-POSITIVE 
BACTERIA EFFECT ON LUNG EPITHELIUM AND 
IMMUNITY 
 
1. D-amino acids and probiotic microbiome 
The lung epithelial interface is constantly in contact with the outside worlds’ 
microbiome (including pathogens and probiotics). A healthy individual remains in a 
state of homeostasis thanks to the lungs immune system. Upon a greater 
inflammation, the individual’s immune system cascade fires up. As soon as 
pathogenic microorganisms and their products try to find their way infecting the 
hosts’ body, the innate response machinery is triggered. Its main line of defense 
consists in phagocytes and PMN; nonspecific leucocytes aiming in killing the infection 
before it starts to spread [5]. This primary cell activation works simultaneously with 
several biological phenomena, such as increased mucus in the lungs, swelling or 
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redness. This study focused mostly on this acute phase and its resolution. After the 
threat, a quick return to the homeostasis is vital for the organism. 
Mammals and in particular humans have evolved to exist and thrive in a quasi-
symbiosis with a multitude of microorganisms. They cover the skin on the outside, 
are present in our lungs, and the digestive tract on inside surfaces. These microbes 
are not only mostly inoffensive, but they are commensal (i.e. beneficial). As such, 
they are non-invasive, and protect the host by competing against the proliferation of 
pathogenic bacteria. 
Different kinds of bacteria shape the lung microbiome; pathogenic (Moraxella 
catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae) as well as 
commensal and even beneficial (Bacillus, Lactobacillus, Lactococcus, Staphylococcus, 
Streptococcus, and Streptomyces). The commensal Gram-positive bacteria 
Lactobacillus casei and other beneficial strains produce D-Trp, a D-amino acid 
recently discovered to be involved in various immunological processes within the 
colonized host [67]. 
L-amino acids are the most common amino acid enantiomer used by mammals [202], 
and are a necessity for the organism, and its immune response [203]. The amino acids 
are the building blocks of the immune proteins’ synthesis (cytokines, and antibodies), 
which are responsible for T cells, B cells, and macrophages activation or proliferation. 
One might not expect that a single amino acid could trigger or influence an immune 
response on its own. However, our data presents in vitro as well as in vivo strong 
immunological evidences towards lung injury resolution due to D-Trp treatment. 
The role of probiotic bacteria has been extensively studied in the gut [204,205], with 
PubMed reaching 11,990 hits as of September 2018 for the keywords “gut 
microbiome”. “Lung microbiome” however totaled 1050 hits, and “lung microbiome 
immunity” a shy 206 hits (Table 6). Only one publication focused on D-Trp and its 
effect regarding airway diseases [67], where D-Trp, and not its L-enantiomer 
successfully reduced CCL17 human Hodgkin lymphoma cell line in vitro as well as 
decreased gut Tregs numbers and Th2 response. The results from this study 
corroborate the one from Kepert et al., where other D-amino acids were found to be 
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immunologically inactive; particularly towards macrophage polarization (Suppl. Fig. 
6). 
 
‘Keywords PubMed hits 
Microbiome 46224 
Gut microbiome 11990 
Lung microbiome 1050 
Gut microbiome immunity 1400 
Lung microbiome immunity 206 
D-Trp gut 2 
D-Trp lung 10 
Table 6. Comparative table of PubMed hits in September 2018 against selected 
keywords. Although the microbiome has been fairly studied; its relation to the lung, and to 
immunity remain poorly understood. The specific role of D-Trp is a very novel topic. 
 
2. D- and L-tryptophan functions 
D-Trp is a byproduct of the peptidoglycan cell wall synthesis in Gram-positive 
bacteria which contains several D-amino acids. However, its roles in bacterial 
signaling and cross signaling are still mostly unknown. In the host, the L-Trp isomer 
is predominant and serves as a precursor for a variety of substrates, the most known 
being serotonin and kynurenine (Suppl. Fig. 10). However, Trp studies used a racemic 
mix or L-Trp only, largely ignoring the D-enantiomer. This created an abundance of 
data regarding the interplay of D-/L-Trp and immunology, scarcely considering the 
specificity of the D-enantiomer of Trp regarding inflammation [67] or microbial 
properties [206]. 
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3. D- and L- amino acids against microbes 
Most L- amino acids promote to variable extents growth and formation of biofilms 
[207]. On the contrary, D-amino acids effects on biofilm formation did not reach a 
general consensus. They have been shown on one hand to inhibit Bacillus subtilis 
biofilm formation [208] or to trigger the biofilm disassembly [209]. On the other hand 
Kao et al. [210] did not observe any inhibitory effect of D-amino acids on 
Pseudomonas aeruginosa’s moderately virulent (PAO1) and virulent (PA14) strains 
[211] biofilm formation, concluding that D-amino acids were not a viable treatment 
against Pseudomonas aeruginosa’s infections. Brandenburg et al. [157] showed that 
bacterial biofilm synthesis on wounds is inhibited by D- and L-Trp. Considering these 
results, it appears that the great diversity of bacteria seems to respond differently 
upon D-Trp supplementation or treatment. Our investigation focuses primarily on the 
effects of D-Trp on mammalian cells described by Kepert et al. [67], and particularly 
on AM and epithelial cells. 
Koseki et al. [212] studied the influence of L- and D-amino acids on bacterial growth 
in vitro. Interestingly, they showed that only D-Trp reduced significantly as an 
incompatible substrate bacterial growth of Listeria monocytogenes, Salmonella 
enterica, and Escherichia coli O157:H7. These results were in contrast with Chan et 
al. [213], who described that D-enantiomers showed less antimicrobial activity, 
although deciding racemic Trp (and Arg) as potential antimicrobial agents. D- and L- 
amino acids have also been used for fighting against pathogens, in the form of 
engineered antimicrobial peptides. Yet, Muñoz et al. [206] showed similar properties 
for the antimicrobial properties of the tryptophan-rich hexapeptide PAF26 for both 
isomers of tryptophan. In this study, alveolar macrophages (AM) Il1b, Tnf and Nos2 
gene expression were compared after exposure to LPS (1 μg/mL) and several D-
amino acids (D-Tyr, D-Phe, D-Met, D-His, D-Pro, and D-Trp). No significant effect 
of D-Tyr, D-Phe, D-Met, D-His, or D-Pro on AM polarization was found for a given 
amino acid concentration of 100 μM (Suppl. Fig. 6). However, D-Trp at 10 μM 
concentration gave a significant stimulation of Mrc1, Arg1 of M2 AM; and Il1b, Tnf 
of M1 AM. 
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4. D-Trp modulates lung immunity 
Knowing that AM are the first responders in the lung [19], this study aimed to 
extend Kepert et al. [67] results to other immune cells, in particular AM. As a proof 
of concept, AM cell line MH-S were polarized (M1 vs M2) and simultaneously treated 
with D-Trp (10-100 μM). As detailed previously, M2 polarization was associated with 
the Th2 major cytokines responses (IL-4 and IL-13), involved during the resolution of 
an infection or injury. Kepert et al. highlighted that on one side oral D-Trp induced 
gut Tregs recruitment and on the other side reduced Th2 numbers and Il-4 levels in 
BALF. IL-4 measurements were not included in this study, considering that the focus 
was drawn on innate immunity. The genetic expression of M1 inflammatory as well 
as M2 resolution markers were measured, illustrating the fact that D-Trp was 
supporting IL-4 dependent M2 polarization (Figure 23) and at the same time 
inhibiting M1 polarization (Figure 21) in vitro at concentrations ranging from 10 to 
100 μM, confirming our initial hypothesis. 
Since D-Trp helped reducing the inflammatory response, it was suggested that this 
effect could be translated to a more complex model of the epithelium injury during a 
coculture model of wound healing. However, D-Trp did not improve wound healing in 
the AECII monolayer culture system. On a singular note, high concentrations of D-
Trp (100 μM) on AECII/AM coculture triggered M0 AM to express key M1 genes 
Il1b and Tnf. It could be explained as a toxic response due to high concentration of 
D-Trp. 
Existing literature is largely incomplete in the case of a lung injury in vivo. Following 
the previous in vitro analysis of D-Trp on an epithelial coculture, it was postulated 
that D-Trp could reduce PMN neutrophil recruitment in the lung after an ALI. This 
animal experiment confirmed the previous in vitro findings, where after LPS (2 
μg/mL, 50 μL) and the subsequent D-Trp inhalation by C57BL/6J mice, significantly 
reduced PMN recruitment in the BAL occurred. This indicates a topical anti-
inflammatory phenomenon, confirming in the lungs Kepert et al. results in the gut. 
Indeed, D-Trp deeply modified the lung immunological landscape, where surface 
markers associated with PMN (i.e. CD11b and Fpr2) were rapidly reduced as well as 
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Alox12 pro-resolving factor expression was impaired in lung homogenate. This is in 
accordance with the time course of the inflammation’s resolution as described by 
Kuhn et al. [172]. 
The strongest cell recruitment reduction was obtained with a D-Trp concentration of 
1 mM. The equivalent condition (1 mM) of L-Trp did not present the same reduction 
of cells recruitment (Figure 28), highlighting the D-Trp stereospecificity effect shown 
by Kepert et al. [67]. This outcome was confirmed by the CCL17 inflammatory 
protein simultaneous decrease in the BALF following ALI and 1 mM D-Trp 
treatment. This data corroborated Thanabalasuriar et al. description of CCL17 as a 
PMN chemoattractant during lung inflammation [214]. Remarkably, these results 
challenged previous finding from Chen et al., where CCL17 cytokine release was 
associated with augmented M2 polarization [215], whereas here, CCL17 secretion was 
reduced (Figure 30) despite D-Trp induced anti-inflammatory responses and M2 
markers increase (Figure 23). Curiously, the overall protein concentration in the BAL 
after LPS instillation was L-Trp and D-Trp independent (40 μg/mL). This can be 
explained by the time course of the experiment and the protein level reaching for 
homeostasis 24h after ALI. Han et al. [216] demonstrated similar results where BAL 
protein levels do not significantly change during the 24h after ALI. 
L- and D-Trp effects on the immune system are mediated via receptors, transporters 
and enzymes; some of them being isomer specific [217]. More importantly, D-Trp 
yielded a better uptake and immunomodulatory potency [218]. Moreover, Trp 
metabolites have been linked to immune modulation through the IDO/kynurenine 
pathway [102,203,217–221]. 
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5. D-Trp, metabolites and AhR signaling 
5.1. D-Trp tolerogenic effect 
Several studies agree that D-Trp and D-/L-Trp (racemic) are ligands to the ligand-
activated transcription factor AhR. Nguyen et al. described how in macrophages and 
DCs, AhR promotes an anti-inflammatory phenotype [222]. Furthermore, in AhR 
deficient mice macrophages produce more pro-inflammatory cytokines [223]. In this 
study, using BMDM cells issued from AhR deficient mice, Kimura et al. results were 
corroborated, highlighting an increase of IL-6 production in LPS stimulated AhR-/- 
macrophages. Besides, the previous findings confirmed that the anti-inflammatory 
mechanisms triggered by D-Trp were AhR dependent. Indeed, the D-Trp 
stereoisomer selectively diminished IL-6 gene expression in a dose dependent manner 
after LPS stimulation of the AhR-/- BMDM. Furthermore, IL-4 treated AhR-/- 
BMDM showed an increased Arg1 gene expression when being D-Trp treated. This is 
consistent with the greater anti-inflammatory response observed in M2 macrophages 
throughout this study. These results support the role of AhR on diminishing acute 
inflammation proposed by Wu et al. [224]. 
In extension to other immune cell studies, these results also reinforce Bruhs et al. 
results, showing that AhR activation leads to immunosuppression by DCs modulation 
[225], suggesting a common AhR dependent tolerogenic effect. 
 
5.2. AhR signaling and kynurenine pathway 
Kynurenine is a Trp metabolite and an AhR ligand, generated after deoxygenation of 
Trp by the IDO1 enzyme. Julliard et al. demonstrated that the IDO1 expression in 
DCs leads to kynurenine accumulation which is tolerogenic, inducing a Tregs increase 
[221]. These results refine a previous study by Munn et al. explaining how the 
degradation of Trp by IDO1 in macrophages leads to suppressed T cells [102].  
Zelante et al. discussed how racemic Trp in the gut [66] leads to Tregs and IL-10 
proliferation, creating an anti-inflammatory phenotype, whereas high concentration of 
Trp leads to the secretion of the inflammatory cytokine IL-22 [219]. Fallarino [220] 
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and Li [226] provide evidence that the metabolites resulting from Trp catabolism are 
responsible for a local tolerogenic environment, essentially by controlling T cells 
homeostasis. 
Results of this PhD thesis reveal that Ido1 is induced in BMDM after high D-Trp 
doses (100 μM) (Figure 34, Figure 36), whether naïve, LPS, or IL-4 treated. This 
conflicts with Musso et al. findings describing that IL-4 influences Trp catabolism by 
inhibiting Ido1 gene expression in PBMC [227]. Considering the similarities between 
BMDM and PBMC, this suggests that the Trp uptake may be stereospecific and that 
Ido1 expression is independent to IL-4.  
Heath-Pagliuso et al. [228] presented that D-Trp activates through AhR signaling 
both the kynurenine and the Cyp1a1 pathways. CYP1A1 is one of the targets of AhR 
signaling (in addition to TLR2 in the gut [229]). As such, it is activated and 
regulated by a variety of hydrocarbons. In particular, it has already been shown that 
Trp and its metabolites are selective AhR modulators [230]. Nguyen et al. [231] 
showed that the D-amino acid oxidase (DAOO) endogenously help the production of 
AhR ligands through the conversion of D-Trp. Consistently, the results showed that 
high doses of D-Trp (100 μM) effectively regulate Cyp1a1 through AhR signaling 
(Figure 34). Moreover, D-Trp displayed a consistent higher potency compared to L-
Trp. This could be explained by a higher affinity of the AhR’s structure towards D-
Trp compared to L-Trp. These results are consistent with the ligand affinity values 
determined by Heath-Pagliuso et al. [228], which show a higher binding potency of D-
Trp to the AhR compared to the L-Trp. However, it is still unclear why the AhR 
favors competitively the D-Trp isomer.  
Additionally, they showed that the Trp metabolites tryptamine (TA) and indole 
acetic acid (IAA) were not only AhR agonists but were also direct Cyp1a1 ligands 
[228]. 
D-Trp reduced Ido1 gene expression (Figure 36). Consequently, it was suggested that 
Ido1 reduced expression would in turn reduce the kynurenine production as well along 
the AhR/kynurenine axis, since Ido1 is indirectly responsible for the kynurenine 
biosynthesis. Several enzymes are responsible for Trp metabolism (IDO2/TDO1/2). 
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However, their stereospecificity have never been studied. Zhang et al. established that 
TDO compensates for IDO1 deficiency. With impaired IDO1, Il-17a was also 
consequently reduced [226], corroborating Li et al.’s findings that Trp catabolism 
induces local immunosuppressive environments by controlling T cells homeostasis 
[226]. 
 
III- CONCLUSIONS AND COMPARISON OF D-TRP AND 
3-OXO-C12-HSL EFFECTS 
 
1. Conclusions 
Since AHL-QS had been discovered to be the cornerstone of bacterial virulence for 
Gram-negative bacteria, various strategies have been set to disrupt QS signaling 
[232–236], along with the inherent ability of mammalian cells to degrade AHL 
through paroxonomase enzymes activity, such as the calcium dependent PON2 
enzyme [91,237]. QS inhibitors such as furanones [238] and antibiotics, impairing 
AHL-QS molecules production, or signal detection, have been proven to be an 
efficient way to selectively inhibit the virulence of Pseudomonas aeruginosa 
[233,234,239]. 
However, over time bacteria have been shown to develop resistance against the hosts’ 
defense strategies. The QS inhibitor brominated furanone C-30 was once found to 
reduce virulence as well as posing little selective pressure on the bacteria [240]. Yet, 
P. aeruginosa developed the C-30-resistant, highly pathogenic, mutant mexR after 
treatment with the inhibitor [241]. In plants, AHL can induce subsequent resistance 
to pathogens through salicylic acid pathway signaling [242]. Conventional antibiotics 
like macrolides have proven their efficiency in regulating bacteria virulence by 
inhibiting biofilm formation. [243]. Nonetheless, hypermutable P. aeruginosa strains 
persist to generate higher antibiotic resistance [244]. 
Following up these results, it was hypothesized that using the QS molecules’ role as 
inter-kingdom mediator would help to positively regulate the host immune system. 
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Indeed, the idea of employing the same mechanisms as some bacteria use to reduce 
lung inflammatory response could largely benefit individual with chronic of acute lung 
inflammatory diseases. Inter-bacterial and cross-kingdom communication represented 
by AHL-QS could lead to better therapy strategies against opportunistic pathogens. 
However, despite promising in vitro results, demonstrating the AHL ability to reduce 
innate inflammation by impairing M1 polarization and promoting M2 polarization, 
could so far not be extended in vivo. Indeed, no significant effect of AHL on 
neutrophil recruitment during ALI was observed, nor any evidence supporting wound 
repair of the epithelium after an injury. However, the model systems and the 
application modes used may have to be developed further to finally succeed in 
positive in vivo responses. 
The immunomodulation specificity of D-Trp over L-Trp, is a novel finding which 
needs further research. In this regard, this study demonstrated that the amino acid 
D-Trp, a metabolite produced by probiotic Gram-positive bacteria like Lactobacillus 
casei strain and others [67], simultaneously impaired the M1 polarization but 
promoted the M2 polarization of AM in vitro. Furthermore, murine intratracheal 
application of D-Trp after acute lung injury reduced neutrophils recruiting, PMN 
associated markers in the lung and CCL17 inflammatory cytokine production in the 
bronchoalveolar lavage (BAL). 
With the help of an AhR-/- mouse model, it was found that D-Trp, a direct agonist of 
the AhR, extinguished IL-6 overexpression in AhR-/- M1 polarized bone marrow 
derived macrophages (BMDM) cells, highlighting an AhR dependent D-Trp 
tolerogenic effect.  
Considering its anti-inflammatory properties as well as its relative low toxicity in 
vivo, the results obtained suggest that D-Trp would make a good candidate towards a 
therapeutic approach against acute and chronic lung diseases as a choice target of the 
aryl hydrocarbon receptor and the downstream regulation of the Th17/Tregs balance. 
The drug delivery method must however be improved, to allow in the future a more 
homogenous dispersion of the D-Trp in lung. D-Trp oral supplementation has to be 
further investigated since initial studies by Kepert et al. [67] showed promising 
DISCUSSION 
110 
results. Future basic research should focus on, and strengthen the link between D-Trp 
pathway, metabolite stereochemistry and receptors affinity as well as other immune 
cells involvements. 
 
2. Comparison of D-Trp and 3-oxo-C12-HSL effects 
In this thesis, the effects of two bacterial molecules on the lung immune system were 
studied: the 3-oxo-C12-AHL, QS-molecule secreted by the Gram-negative 
Pseudomonas aeruginosa’s AHL-QS system, and the D-Trp amino acid, secreted 
(among others) by the Gram-positive, probiotic bacterium Lactobacillus casei. 
Both molecules shared in vitro a couple of key features. They demonstrated evidence 
of impaired pro-inflammatory gene expression of M1 in AM cell line culture (Figure 
10 and Figure 21). In a coculture model of alveolar epithelial cell type 2 (AECII) and 
AM (Figure 15), the 3-oxo-C12-AHL, but not D-Trp, caused a reduced expression of 
pro-inflammatory genes (Figure 15). D-Trp and 3-oxo-C12-AHL treatment increased 
key anti-inflammatory gene expression in M2 AM, thus further supporting M2 
polarization of M2 AM. 
Neither D-Trp nor 3-oxo-C12-AHL supported wound repair in an epithelium wound 
healing assay consisting in a bilayer of AECII and AM. However, the 3-oxo-C12-AHL 
notably resulted in more cytotoxicity of the epithelium.  
An in vivo model of acute lung injury was carried out. LPS was applied 
intratracheally prior to the application of D-Trp or 3-oxo-C12-AHL. The immune 
response was quantified by the amount of PMN in the inflamed bronchoalveolar 
lavage (BAL). D-Trp, but not 3-oxo-C12-AHL, displayed a reduction in PMN and 
protein concentration in the BAL (Figure 28). This result was followed in its 
downstream signaling and linked to the AhR pathway. These findings suggest D-Trp 
as a possible candidate for further studies of bacteria-host interactions in the lung. 
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SUPPLEMENTARY FIGURES 
 
Suppl. Fig. 1. Rosiglitazone (RGZ) pre-treatment on M1 cells reduced Tnf 
expression after stimulation with 3-oxo-C12-HSL. Joint RGZ/AHL effect on M1 
polarized cells was studied in a time response experiment (24h). All cells were LPS 
(1 μg/mL)/AHL (60 μM) or LPS (1 μg/mL)/RGZ (60 μM) co-stimulated for 6h and then 
stimulated with RGZ or AHL respectively. ACN: Acetonitrile solvent control (0.2%). (mRNA 
expression is relative to Hprt, n=3, values represent the mean ± SEM). 
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Suppl. Fig. 2. 3-oxo-C12-HSL selectively impairs wound closure of AECII 
monolayer and AECII/AM coculture independently of LPS. LA-4/MH-S cells were 
cultivated from 0 to 24h after simultaneous scratch and treatment with ACN (0.6%)/3-oxo-
C12-HSL (60μM)/3-oxo-C4-HSL (60μM)/C12-HSL (60μM)/RGZ (60μM)/LPS (1 μg/mL). 
Wound widths were determined 0 and 24 hours after wounding. ACN: Acetonitrile solvent 
control (0.2%). (n=3, values represent the mean ± SEM, *: p<0.05) 
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
SL
R
G
Z
0
20
40
60
80
100
*
LA-4/MH-S + AHL
A
LA-4 + AHL
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
SL
R
G
Z
0
50
100B
RGZ
ACN
3-oxo-C12-HSL
3-oxo-C4-HSL
C12-HSL
LA-4 + AHL/LPS
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
S
L
R
G
Z
0
50
100
**
D
ACN
3-oxo-C12-HSL
3-oxo-C4-HSL
C12-HSL
RGZ
%
 w
o
u
n
d
 c
lo
s
u
re
A
C
N
3-
ox
o-
C
12
-H
S
L
3-
ox
o-
C
4-
H
S
L
C
12
-H
S
L
R
G
Z
0
20
40
60
80
100
**
LA-4/MH-S + AHL/LPS
C
 
 
Suppl. Fig. 3. 3-oxo-C12-HSL/LPS treatment reduces Tas2r138 mRNA 
expression in AM/AECII coculture. MH-S/LA-4 cells were incubated 24h after 
AHL/LPS treatment. The mRNA expression is relative to Hprt. 
M0: no polarization; M1: LPS (1 μg/mL). (n=3, values represent the mean ± SEM) 
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Suppl. Fig. 4. Microarray analysis of gene expression of isolated and polarized 
wild type alveolar macrophages. Data shows gene expression, a value under 100 is 
considered low expression - Ingenuity software (Qiagen). 
 
Symbol 
WT_M0 
Expression 
WT_M1 
Expression 
WT_M2 
Expression 
Tas1r1 59 58 64 
Tas1r2 77 55 69 
Tas1r3 65 70 85 
Tas2r102 60 61 56 
Tas2r104 62 66 59 
Tas2r105 93 101 97 
Tas2r106 63 67 63 
Tas2r107 65 68 70 
Tas2r4 44 44 43 
Tas2r109 62 72 74 
Tas2r110 82 84 80 
Tas2r113 61 61 62 
Tas2r10 73 69 73 
Tas2r115 80 75 77 
Tas2r116 48 54 53 
Tas2r117 48 47 50 
Tas2r117 47 40 45 
Tas2r16 70 74 59 
Tas2r1 88 84 80 
Tas2r46 72 72 69 
Tas2r13 64 62 59 
Tas2r123 53 58 53 
Tas2r124 96 108 90 
Tas2r125 93 90 89 
Tas2r41 123 118 121 
Tas2r129 58 67 66 
Tas2r7 81 88 92 
Tas2r42 47 51 48 
Tas2r134 62 52 65 
Tas2r60 60 49 53 
Tas2r31 62 64 61 
Tas2r3 52 55 45 
Tas2r39 52 60 59 
Tas2r14 56 52 50 
Tas2r143 47 62 52 
Tas2r143 69 57 66 
Tas2r40 74 79 74 
SUPPLEMENTARY FIGURES 
114 
Suppl. Fig. 5. Low dose of D-Trp (<300 μM) inhibited CD36 expression when 
co-treated with RGZ before being LPS stimulated. Tnf expression is reduced in 
the same conditions. CD36 is a surface marker induced by RGZ [153]. Joint RGZ/D-Trp 
effect on M1 polarized cells was studied in a dose-time response experiment (24h). MH-S cells 
were either RGZ/D-Trp or RGZ/D-Trp/LPS stimulated for 6h and then further stimulated 
with LPS or PBS respectively. mRNA expression is relative to Hprt (n=3). Control: PBS 
solvent. (Values represent the mean ± SEM). 
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Suppl. Fig. 6. Low doses of D-Trp (10 μM) increased Il1b expression in M1 
polarized cells as well as Mrc1 and Arg1 expression in M2 polarized cells. DMSO 
1%, All D-amino acids (100μM, DMSO 1%) are used as controls. mRNA expression is relative 
to Hprt (n=3). M0: no polarization; M1: LPS (1 μg/mL); M2: IL-4 (20 ng/mL). (Values 
represent the mean ± SEM) 
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Suppl. Fig. 7. CCL17, CXCL1 and TNFα  cytokines concentrations in the BAL 
are reduced after D-Trp instillation and ALI in vivo. ELISA assay of the correlation 
between protein concentration and cell numbers 24h after D-Trp/L-Trp (1 mM) and ALI. 
BAL cells consist mostly of AM and PMN. The data points are the cumulation of ELISA 
BAL experiments (n=5-8). 
 
 
 
Suppl. Fig. 8. TNF signaling pathway. TNFα is one of the key inflammatory cytokines 
and its release is a robust indicator of classically activated macrophages. (Generated from 
www.genome.jp/kegg/). 
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Suppl. Fig. 9. Phenylalanine, Tyrosine and Tryptophan biosynthesis pathway 
map in fungi, bacteria and plants. These metabolites will then be catabolized in the food 
chain in eukaryotic mammalian species. (Generated from www.genome.jp/kegg/). 
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Suppl. Fig. 10. Tryptophan metabolism pathway map. D-Trp and L-Trp are both 
metabolized by mammalian organisms through the same enzymes of the kynurenine pathway. 
(Generated from www.genome.jp/kegg/) 
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Suppl. Fig. 11. Biosynthesis of the acute inflammation mediators leading to the 
activation of FPR2/ALXR receptors. Diagram of the acute inflammatory response. In 
blue: the onset. In red: the propagation. In green: the resolution [245]. 
 
 
 
Suppl. Fig. 12. Microbiota: commensal vs pathogenic. Diagram of the underlying 
mechanism of airway inflammation. Adapted from [246].  
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ABBREVIATIONS 
Ab Antibody 
ABP Activity-based probe 
ACN Acetonitrile 
Actb Actin, beta 
AECII Alveolar Epithelial Cells type 2 
AHL N-Acyl Homoserine Lactones 
AP-1 Activator protein 1 
ALI Acute lung injury 
AM Alveolar Macrophage 
APC Antigen presenting cell 
AQ 2-alkyl-4(1H)-quinolone 
Arg1 Arginase 1 
BAL Bronchoalveolar lavage 
BMDM Bone Marrow Derived Macrophage 
BSA Bovine serum albumin 
CCL17 Chemokine (C-C motif) ligand 17 
CCL2 Chemokine (C-C motif) ligand 2 
CD Cluster of differentiation 
cDNA Complementary DNA 
COPD Chronic obstructive pulmonary disease 
CpG CpG motifs 
CSF-2 Colony stimulating factor 2 
Ct Cycle threshold 
CXCL5 C-X-C motif chemokine 5 
DAAO D-amino acid oxidase 
DCs Dendritic cells 
DMEM Dulbecco's Modified Eagle Medium 
ABREVIATIONS 
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DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
D-Phe/His/Met/ 
Pro/Tyr/Trp 
D-Phenylalanine/Histidine/Methionine/Proline/Tyrosine/ 
Tryptophan 
EDTA Ethyldiaminetetraacetate 
ELISA Enzyme-linked immunosorbent assay 
FACS Fluorescence-activated cell sorting (flow cytometry) 
FBS Fetal Bovine Serum 
HDL High-density lipoprotein 
HRP Horseradish peroxidase 
HSL Homoserine Lactone 
IAA Indole acetic acid 
IDO1/2 Indoleamine 2,3-dioxygenase 1/2 
IL-12β Interleukin 12 beta 
IL-1β Interleukin-1 beta 
IL-4Rα Interleukin-4 receptor alpha chain 
IL-6 Interleukin 6 
iNOS Inducible nitric oxide synthase 
IPF Idiopathic pulmonary fibrosis 
IRF Interferon-regulatory factor 
JAK Janus Kinase 
KO, -/- Knock out 
LasI Acyl-homoserine-lactone synthase 
Lcn2 Lipocalin-2 
LPS Lipopolysaccharides 
M1 macrophage Classically activated macrophage 
M2 macrophage Alternatively activated macrophage 
M-CSF Macrophage colony-stimulating factor 
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MHC Major histocompatibility complex 
MRC1 Mannose Receptor C-Type 1 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NRQ Normalized relative quantity 
OD Optical density 
PAO1 Pseudomonas aeruginosa strain PAO1 
P/S Penicillin/Streptomycin 
PBS Phosphate buffer saline 
PBMC Peripheral blood mononuclear cell 
PBST Phosphate buffered saline with Tween 20 
PCR Polymerase chain reaction 
PMA Phorbol 12-myristate 13-acetate 
PMN Polymorphonuclear neutrophil 
PRR Pattern recognition receptor 
qPCR Quantitative real-time polymerase chain reaction 
QS Quorum sensing 
Retnlα Resistin-like molecule alpha 
Rhl Acyl-homoserine-lactone synthase 
RIPA Radioimmunoprecipitation assay buffer 
RGZ Rosiglitazone 
RNA Ribose nucleic acid 
RT Room temperature 
RT-PCR Reverse transcription PCR 
SAA Serum amyloid A 
SEM Standard error of the mean 
STAT Signal transducer and activator of transcription 
T2R38 Taste receptor, Type 2, Member 38 
TA Tryptamine 
TCR T cell receptor 
ABREVIATIONS 
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TDO Tryptophan 2,3-dioxygenase 
TEMED Tetramethylethylenediamine 
TGFβ Transforming growth factor beta 
Th T helper cells 
TLR Toll-like receptor 
TNFα Tumor necrosis factor α 
Treg Regulatory T cell 
WT Wild type 
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